Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia
Open accessAbstract
SIGNIFICANCE: Recent clinical evidence identified anemia to be correlated with severe complications of cardiovascular disease (CVD) such as bleeding, thromboembolic events, stroke, hypertension, arrhythmias, and inflammation, particularly in elderly patients. The underlying mechanisms of these complications are largely unidentified. Recent Advances: Previously, red blood cells (RBCs) were considered exclusively as transporters of oxygen and nutrients to the tissues. More recent experimental evidence indicates that RBCs are important interorgan communication systems with additional functions, including participation in control of systemic nitric oxide metabolism, redox regulation, blood rheology, and viscosity. In this article, we aim to revise and discuss the potential impact of these noncanonical functions of RBCs and their dysfunction in the cardiovascular system and in anemia. CRITICAL ISSUES: The mechanistic links between changes of RBC functional properties and cardiovascular complications related to anemia have not been untangled so far. FUTURE DIRECTIONS: To allow a better understanding of the complications associated with anemia in CVD, basic and translational science studies should be focused on identifying the role of noncanonical functions of RBCs in the cardiovascular system and on defining intrinsic and/or systemic dysfunction of RBCs in anemia and its relationship to CVD both in animal models and clinical settings. Antioxid. Redox Signal. 26, 718-742.
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that red blood cells (RBCs) have noncanonical roles in redox regulation, nitric oxide (NO) metabolism, blood rheology, and erythrocrine signaling, and that RBC dysfunction may contribute mechanistically to anemia-associated cardiovascular complications. It synthesizes basic, translational, and clinical evidence and calls for studies distinguishing intrinsic RBC dysfunction from reduced RBC number in anemia.
Key findings
- RBCs are highly exposed to oxidants: about 3% of hemoglobin undergoes autoxidation every 24 h, yet only about 1% of Hb is present as methemoglobin; RBCs contain 10 mM heme and maintain 90%–95% of glutathione in the reduced GSH form.
- RBCs were traditionally viewed as NO scavengers, but intact RBCs consume NO with a 1000-fold discrepancy compared with free Hb; proposed RBC-mediated NO pathways include deoxyhemoglobin-catalyzed nitrite reduction, with one study proposing only 25% of nitrite is directly reduced to NO, plus RBC eNOS and ATP release.
- Anemia is defined as Hb <12 g/dL in females and <13 g/dL in males; 20%–30% of patients with cardiovascular disease (CVD) have concomitant anemia, and elderly patients aged 65+ have a 10% higher risk of anemia, rising to 20% in those aged 85+.
- In β-thalassemic mice, heme degradation products were increased 3.5-fold; mouse models in Table 1 cover disorders of erythropoiesis, increased hemolysis/RBC depletion, blood loss, and RBC distribution.
Methods
- Design: narrative review, not a primary experimental study; it synthesizes mechanistic, animal-model, and clinical literature.
- Data/sample: cited basic science studies, transgenic and knockout mouse models (Table 1), and clinical/epidemiological evidence on anemia and CVD.
- Main analysis: conceptual synthesis of RBC redox regulation, NO metabolism, mechanical/rheological properties, anemia pathophysiology, and therapeutic approaches including transfusion and erythropoiesis-stimulating agents (ESAs).
Limitations
- The paper states that mechanistic links between changes in RBC functional properties and cardiovascular complications related to anemia have not been untangled, and that many aspects of RBC-mediated NO metabolism and ATP release remain speculative or not universally accepted.
- The paper notes that interpretation of large cohort/epidemiological studies is complex and requires recognition of many interacting disease and physiological features.
- Evident from the text: as a narrative review, it presents no new experimental data and does not describe a systematic search strategy or formal quality appraisal.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 198 cited sources checked · 0 supported · 0 flagged
- Findingcitation
The effects of NO donors on RBC deformability ex vivo were not confirmed by others.
“However, recently, the effects of NO donors on RBCs deformability ex vivo were not confirmed by others (15).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] source
Not checked in the free run.
- Premisecitation
In healthy human RBCs, 90%-95% of glutathione is present in the reduced form GSH.
“In healthy human RBCs, 90%–95% of glutathione is present in the reduced form GSH (200) that can be utilized for the reduction of ascorbate, oxidized proteins, and oxidized lipids (184).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [200] source
Not checked in the free run.
- Premisecitation
GSH can be utilized for the reduction of ascorbate, oxidized proteins, and oxidized lipids.
“In healthy human RBCs, 90%–95% of glutathione is present in the reduced form GSH (200) that can be utilized for the reduction of ascorbate, oxidized proteins, and oxidized lipids (184).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [184] source
Not checked in the free run.
- Premisecitation
The reaction between H2O2 and both ferrous and ferric hemoglobin results in heme degradation and release of free iron.
“Another important oxidative pathway is the reaction between H2O2 and both ferrous and ferric Hb, resulting in heme degradation and release of free iron (3), as described in detail in an older comprehensive review by Reeder (150).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Lack of riboflavins can impair antioxidant defense in fasting.
“In addition, the lack of riboflavins—components of the cosubstrate flavin adenine dinucleotide (FAD) important for glutathione reductase functionality—can impair antioxidant defense in fasting (10).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] source
Not checked in the free run.
- Interpretationreasoning
Considering the abundance of hemoglobin in RBCs (10 mM heme), autoxidation of hemoglobin is the most abundant source of reactive oxygen species in RBCs.
“Considering the abundance of Hb in RBCs (corresponding to 10 mM heme), the reaction of autoxidation of Hb is therefore the most abundant source of ROS in RBCs.”
Quote in the paperNot a substantial claim - Premisecitation
The major transport mechanism of ascorbate into the RBC is attributed to glucose transporter 1.
“The major transport mechanism of ascorbate into the RBC is attributed to glucose transporter 1 (116, 130).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The enzymes known to participate in the processing of oxidants in mature RBCs are SOD1, catalase, glutathione peroxidase, and peroxiredoxin 2.
“The enzymes known to participate in the processing of oxidants in mature RBCs are SOD1, Cat, GPx, and Prx2 (129).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [129] source
Not checked in the free run.
- Premisecitation
The superoxide anion is formed in RBCs mostly by hemoglobin autoxidation.
“Of high importance for the mature RBC is the copper/zinc isoform 1 of SODs (SOD1), catalyzing the dismutation of the superoxide anion (Eq. 9), which is formed in RBCs mostly by Hb autoxidation (Eq. 1), into hydrogen peroxide (122).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [122] McCord JM, 1969, J Biol Chem source
Not checked in the free run.
- Premisecitation
Therapeutic interventions aimed to increase the circulating number of RBCs (transfusion of blood or administration of erythropoiesis-stimulating agents) were not always effective in the tested cohorts.
“However, therapeutic interventions aimed to increase the circulating number of RBCs (e.g., by transfusion of blood or by administration of erythropoiesis-stimulating agents [ESAs] to stimulate the production of RBCs by the bone marrow), were not always effective in the tested cohorts (48, 91, 156).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Recycling of α-tocopherol radicals occurs by the oxidation of ascorbate.
“It was demonstrated that recycling of α-tocopherol radicals, next to diffusion of new molecules out of plasma, occurs by the oxidation of ascorbate (24, 121).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Free iron (Fe3+) may dissociate from methemoglobin.
“Another source of oxidants is free iron (Fe3+), which may dissociate from metHb (26).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] Bunn HF, 1968, J Biol Chem source
Not checked in the free run.
- Premisecitation
Treatment with erythropoiesis-stimulating agents was associated with increased thromboembolic events.
“One possible explanation is that these treatments have side effects and therefore may contribute themselves to the negative outcome, for example, treatment with ESAs was associated with increased thromboembolic events (45).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] source
Not checked in the free run.
- Premisecitation
Every 24 h, 3% of hemoglobin undergoes autoxidation, producing methemoglobin and superoxide radical anion.
“Every 24 h, 3% of Hb undergoes autoxidation, producing metHb and superoxide radical anion (Eq. 1) (50).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] source
Not checked in the free run.
- Premisecitation
SOD1 catalyzes the dismutation of the superoxide anion into hydrogen peroxide.
“Of high importance for the mature RBC is the copper/zinc isoform 1 of SODs (SOD1), catalyzing the dismutation of the superoxide anion (Eq. 9), which is formed in RBCs mostly by Hb autoxidation (Eq. 1), into hydrogen peroxide (122).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [122] McCord JM, 1969, J Biol Chem source
Not checked in the free run.
- Premisecitation
Cys-93 in the β-subunit of hemoglobin (where S-nitrosohemoglobin is formed) is not essential for RBC-dependent hypoxic vasodilation.
“In contrast, another study demonstrated that Cys-93 in the β-subunit of Hb (where this nitrosothiol is formed) is not essential for RBC-dependent hypoxic vasodilation (83), thus implicating other NO metabolites or pathways.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [83] source
Not checked in the free run.
- Premisecitation
In nonpathological conditions, glutathione peroxidase is the enzyme degrading most of the H2O2 by oxidizing reduced GSH into GSSG.
“In nonpathological conditions, GPx has been shown to be the enzyme degrading most of the H2O2 by oxidizing reduced GSH into GSSG (Eq. 10).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] source
Not checked in the free run.
- Premisecitation
In conditions of overproduction of O2•− and therefore higher concentrations of H2O2, catalase takes over and reduces H2O2 into water.
“In conditions of overproduction of O2•− and therefore higher concentrations of H2O2, Cat takes over and reduces H2O2 into water (Eqs. 11 and 12) (89).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [89] source
Not checked in the free run.
- Premisecitation
In vitro experiments have shown that there is a 1000-fold discrepancy between the reaction with free hemoglobin or intact RBCs.
“However, in vitro experiments have shown that there is a 1000-fold discrepancy between the reaction with free Hb or intact RBCs (111).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [111] source
Not checked in the free run.
- Premisecitation
The association of Prx2 with the membrane makes it important for protection of RBC membrane constituents against lipid peroxidation.
“The association of Prx2 (which participates in reduction of organic peroxides, Eq. 13) with the membrane (120) makes it important for protection of RBC membrane constituents against lipid peroxidation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [120] source
Not checked in the free run.
- Premisecitation
Malfunction of antioxidant defense and/or conditions of increased oxidant production have severe consequences for RBCs on a subcellular level.
“Malfunction of antioxidant defense and/or conditions of increased oxidant production have severe consequences for RBCs on a subcellular level.”
Quote in the paperSubstantial claim0 of 5 sources checked - Interpretationcitation
Red cell eNOS-derived NO may play a role in controlling cardiovascular hemodynamics.
“These results show that not only nitrite-derived NO production by RBCs under hypoxic conditions but also red cell eNOS-derived NO may play a role in controlling cardiovascular hemodynamics.”
Quote in the paperSubstantial claim - Interpretationreasoning
This may explain lower consumption of NO by RBCs compared with free hemoglobin.
“This may explain lower consumption of NO by RBCs compared with free Hb.”
Quote in the paperSubstantial claim - Premisecitation
Chimera mice lacking eNOS in blood have increased infarct sizes after myocardial ischemia/reperfusion injury.
“as well as increased infarct sizes after myocardial ischemia/reperfusion injury (73, 125).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Shear stress, hypoxia, or pharmacological stimuli such as β-adrenergic receptor stimulation activate signaling cascades leading to release of ATP from RBCs through cystic fibrosis transmembrane conductance regulator or pannexin 1 channels.
“Shear stress, hypoxia, or pharmacological stimuli, such as β-adrenergic receptor stimulation, have been shown to activate signaling cascades leading to release of ATP through cystic fibrosis transmembrane conductance regulator or pannexin 1 channels (36, 53).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Under conditions of decreased oxygen saturation, RBCs induce vasodilation of vessel strips by exporting NO bioactivity.
“This view changed radically after the discovery of RBC-mediated hypoxic vasodilation: under conditions of decreased oxygen saturation, RBCs were shown to induce vasodilation of vessel strips by exporting NO bioactivity (146).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [146] source
Not checked in the free run.
- Premisecitation
RBC-mediated nitrite reduction and subsequent inhibition of platelet aggregation do not take place with nitrite alone.
“The latest hypothesis is supported by the fact that RBC-mediated nitrite reduction and subsequent inhibition of platelet (PLT) aggregation do not take place with nitrite alone (2, 144).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
A lack of Prx2 has greater impact on the phenotype than lack of glutathione peroxidase or catalase.
“A lack of this enzyme has greater impact on the phenotype than lack of GPx or Cat (106).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [106] source
Not checked in the free run.
- Interpretationreasoning
Failure or dysfunction of the antioxidant system may have severe consequences for the cell, including loss of membrane integrity leading to hemolytic anemia.
“Failure or dysfunction of the antioxidant system may have severe consequences for the cell, including loss of membrane integrity leading to hemolytic anemia.”
Quote in the paperSubstantial claim - Premisecitation
RBCs contain high concentrations of nitrite in an arterial-venous gradient.
“The observation that RBCs contain high concentrations of nitrite (44) in an arterial-venous gradient (72) and that deoxyhemoglobin catalyzes nitrite reduction started a lively debate about the origin of NO released from RBCs—whether by formation of S-nitrosohemoglobin or nitrite reduction by Hb.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Hemoglobin rapidly inactivates the NO signal by binding NO to the oxygenated Fe2+-heme metal center, followed by formation of methemoglobin and nitrate with a high reaction constant of ≈6-8 × 107 M−1s−1.
“Hb is thought to rapidly inactivate the NO signal by binding NO to the oxygenated Fe2+-heme metal center, which is followed by subsequent formation of metHb and nitrate with a high reaction constant of ≈6–8 × 107 M−1s−1 (Eq. 15) (81).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [81] source
Not checked in the free run.
- Premisecitation
Decreased hematocrit due to iron deficiency anemia may decrease RBC-mediated NO scavenging, leading to hypotension.
“On the other hand, it was shown that a decreased hematocrit due to iron deficiency anemia may decrease RBC-mediated NO scavenging, leading to hypotension (140).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [140] source
Not checked in the free run.
- Premisecitation
Endothelial alpha globin regulates NO availability via direct interaction with eNOS.
“Functionally, the endothelial alpha globin was shown to regulate NO availability via direct interaction with eNOS in these cells (171).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [171] source
Not checked in the free run.
- Premisereasoning
RBCs dominate viscosity calculations due to their high preponderance.
“Although RBCs are not the only factor in blood that can cause a change in viscosity, they dominate viscosity calculations due to their high preponderance.”
Quote in the paperNot a substantial claim - Interpretationreasoning
RBC intrinsic elastic properties depend on cell geometry, intracellular viscosity, and flexibility of the cytoskeleton.
“These intrinsic elastic properties of RBCs depend on structural and biophysical characteristics, including cell geometry, intracellular viscosity, and flexibility of the cytoskeleton.”
Quote in the paperSubstantial claim - Premisecitation
Increased cholesterol and phospholipid ratios in RBC membranes are correlated with decreased RBC deformability.
“Increased cholesterol and phospholipid ratios in the membranes of RBCs are correlated with decreased RBC deformability (25, 123).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisenone given
In high shear rates, RBCs elongate along the principal ellipsoid axis.
“In high shear rates, elongation of the principal ellipsoid axis is observed.”
Quote in the paperNot a substantial claim - Premisecitation
Shear stress is an important activator of NO production in the endothelium.
“One important activator of production of NO in the endothelium is shear stress (43, 163).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Loss of deformability in RBCs may increase blood viscosity significantly due to increased end-over-end tumbling.
“a loss of deformability in RBCs may increase viscosity significantly (34) due to increased end-over-end tumbling (61).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Spectrin provides stability under shearing forces by cross-linking actin with other RBC membrane proteins.
“Additionally, spectrin provides stability under a variety of shearing forces by cross-linking actin with other RBC membrane proteins (177).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [177] source
Not checked in the free run.
- Premisecitation
Hb-α is expressed in myoendothelial junctions in resistance vessels without its β subunit partner.
“Hb-α was found to be expressed in myoendothelial junctions (connection between endothelium and smooth muscle) in resistance vessels without its β subunit partner (172).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [172] source
Not checked in the free run.
- Interpretationreasoning
The combination of RBC motions links individual cell properties with overall rheology of blood.
“The combination of all of these motions links individual cell properties with the overall rheology of blood.”
Quote in the paperNot a substantial claim - Premisereasoning
The intrinsic ability of RBCs to change shape is mainly defined by flexibility and stability of the inner membrane-attached cytoskeleton.
“The intrinsic ability of RBCs to change their shape is mainly defined by their flexibility as well as stability of the inner membrane-attached cytoskeleton.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Control of redox state of Hb in both RBC and vascular compartments is responsible for systemic control of NO bioavailability, NO metabolism, and fine regulation of cardiovascular hemodynamics.
“This makes an important parallel between RBC Hb and vascular Hb, where control of redox state of Hb in both compartments is responsible for systemic control of NO bioavailability, NO metabolism, and results in fine regulation of cardiovascular hemodynamics, further underscoring the importance of NO bioavailability in both systems.”
Quote in the paperSubstantial claim - Premisecitation
Administration of NOS inhibitors decreases RBC deformability as assessed by ektacytometry.
“Administration of NOS inhibitors decreased RBC deformability as assessed by ektacytometry (22)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] source
Not checked in the free run.
- Premisecitation
Fine-tuning of NO diffusion from the endothelium to the smooth muscle cell is controlled by regulation of its Fe2+/Fe3+ redox equilibrium.
“Fine-tuning of NO diffusion from the endothelium to the smooth muscle cell is controlled by regulation of its Fe2+/Fe3+ redox equilibrium (172).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [172] source
Not checked in the free run.
- Premisecitation
The mode of RBC deformation depends heavily on internal viscosity of the cell and membrane viscosity, with greater deformation at lower λ values.
“Early work on the fluid dynamics of RBCs determined that the form of deformation depends heavily on both the internal viscosity of the cell and the membrane viscosity. The ratio of cytoplasmic and external viscosities (often termed lambda, λ) determines the mode of deformation, with a greater deformation at lower λ values (148).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [148] Pfafferott C, 1985, Effects of internal and external phase viscosity and of in vivo aging. Biophys J
Not checked in the free run.
- Premisecitation
Changes in the redox state of RBCs by alkylating agents, superoxide-generating systems, and peroxides strongly affect RBC deformability.
“Changes in the redox state of RBCs by treatment with alkylating agents, superoxide-generating systems, and peroxides strongly affect RBC deformability (12).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] source
Not checked in the free run.
- Premisecitation
In the microcirculation of the chorioallantoic membrane of the chicken egg, eNOS inhibition and NO donors affect RBC deformation and velocity independently from changes of vascular diameter.
“In microcirculation of the chorioallantoic membrane of the chicken egg, eNOS inhibition and NO donors affected RBC deformation and velocity independently from changes of the vascular diameter (82)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [82] source
Not checked in the free run.
- Premisecitation
The discoid shape of RBCs is defined by cytoskeletal structural proteins and ion channels.
“The discoid shape is defined by cytoskeletal structural proteins and ion channels (127).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [127] source
Not checked in the free run.
- Interpretationcitation
RBC intrinsic properties, together with mechanisms regulating vascular tone and cardiac function, contribute to regulation of blood rheology, peripheral resistance, and cardiac function.
“These RBC intrinsic properties, together with the mechanisms regulating vascular tone and cardiac function, contribute to regulation of blood rheology, peripheral resistance, and cardiac function (114, 168, 188).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisenone given
Membrane tanktreading creates lift forces that push individual RBCs away from vessel walls and into the center of the blood stream.
“Tanktreading is a favorable deformation mode because it creates lift forces that push individual RBCs away from vessel walls and into the center of the blood stream, where the flow is greatest.”
Quote in the paperNot a substantial claim - Interpretationreasoning
RBC structural and biophysical characteristics are optimized for canonical functions such as gas transport and exchange to the tissues.
“RBC structural and biophysical characteristics are optimized for canonical functions of RBCs such as gas transport and exchange to the tissues.”
Quote in the paperSubstantial claim - Premisecitation
G6PDH deficiency imparts different phenotypes, from acute hemolytic anemia to chronic hemolysis.
“G6PDH deficiency is one of the most common enzyme defects in humans due to multiple mutations of the G6PDH gene and imparts different phenotypes, from acute hemolytic anemia to chronic hemolysis (30).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] source
Not checked in the free run.
- Premisereasoning
A decrease in GSH and in GSH/GSSG ratio leads to a decrease in enzymatic activity of GPx and GRx, which use GSH as a cofactor.
“A decrease in GSH and in GSH/GSSG ratio leads to a decrease in enzymatic activity of GPx and GRx, which use GSH as a cofactor (Fig. 2).”
Quote in the paperSubstantial claim - Premisecitation
Homozygous mice carrying genes encoding incomplete spectrin subunits develop severe anemia and dramatically decreased RBC lifetime.
“Homozygous mice carrying genes encoding for incomplete spectrin subunits result in severe anemia and dramatically decreased lifetime of RBCs (19).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] source
Not checked in the free run.
- Premisecitation
Genetic deficiency of the cytosolic Prx1 in mice results in a severe anemic phenotype due to oxidative damage of the RBC membrane and cytosolic proteins.
“Genetic deficiency of the cytosolic Prx1 in mice results in a severe anemic phenotype due to oxidative damage of the RBC membrane and cytosolic proteins (139).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [139] source
Not checked in the free run.
- Premisereasoning
Genetic deficiency of antioxidant enzymes including SOD1 and 2, Prx1 and 2, and Nrf2 can cause decreased redox capacity and hemolytic anemia.
“Examples of genetic defects inducing redox dysregulation and hemolytic anemia are the genetic deficiency of G6PDH (well-characterized human disease) and the genetic deficiency of antioxidant enzymes, including SOD1 and 2, Prx1 and 2, and nuclear factor E2-related factor 2 (Nrf2, a transcription factor controlling expression of multiple antioxidant and detoxifying enzymes).”
Quote in the paperNot a substantial claim - Premisecitation
Loss of RBCs due to acute or chronic bleeding is another important cause of anemia.
“Another important cause of anemia is the loss of RBCs due to acute or chronic bleeding (59).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [59] source
Not checked in the free run.
- Premisecitation
Acute hemolytic anemia in G6PDH deficiency occurs only when triggered with certain drugs, infections, or pro-oxidative ingredients in food.
“Most G6PDH-deficient patients are asymptomatic throughout their lifetime and acute hemolytic anemia only occurs when triggered with certain drugs (antimalarial drugs such as primaquine), infections (hepatitis A virus), or pro-oxidative ingredients in food [e.g., fava beans, as already observed by the antiques (30)].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] source
Not checked in the free run.
- Premisenone given
An increase in GSSG and decrease of GSH/GSSG ratios were reported in sickle RBCs, resulting in decreased antioxidative capacity.
“An increase in GSSG and decrease of GSH/GSSG ratios were reported in sickle RBCs, resulting in decreased antioxidative capacity.”
Quote in the paperNot a substantial claim - Premisecitation
Hb degradation in thalassemia leads to release of heme and iron, which can catalyze the Fenton reaction.
“Hb degradation leads to the release of heme and iron, which can serve as a catalyst for the Fenton reaction (165) (Fig. 2 and Eq. 3).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [165] Shinar E, 1990, Semin Hematol
Not checked in the free run.
- Premisecitation
Sickle cells produce greater amounts of O2•−, H2O2, and hydroxyl radical •OH compared with healthy RBCs.
“It has been reported that sickle cells produce greater amounts of O2•−, H2O2, and hydroxyl radical •OH compared with healthy RBCs (8, 80, 100).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationreasoning
With regard to SOD1, scavenging of hydrogen peroxide in proximity to the membrane is more important than the interception of cytosolic hydrogen peroxide.
“Since Prx2 is localized on/next to the membrane, these data suggest that with regard to SOD 1, scavenging of hydrogen peroxide in proximity to the membrane is more important than the interception of cytosolic hydrogen peroxide (106).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [106] source
Not checked in the free run.
- Interpretationreasoning
Dysfunction of intrinsic homeostatic mechanisms in RBCs may lead to anemic conditions both in humans and in mice.
“Dysfunction of intrinsic homeostatic mechanisms in RBCs may lead to anemic conditions both in humans and in mice.”
Quote in the paperSubstantial claim - Premisecitation
In a rat model of iron deficiency anemia, expression and activity of eNOS were increased in the aorta and in the kidney.
“In a rat model of iron deficiency anemia, expression and activity of eNOS were increased in the aorta and in the kidney (140), pointing to a further mechanism leading to increase in NO bioavailability in anemia.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [140] source
Not checked in the free run.
- Premisecitation
Under chronic anemic conditions, adjustments that initially increase cardiac output lead to left ventricular enlargement and eccentric left ventricular hypertrophy.
“Under chronic anemic conditions, adjustments that initially increase cardiac output lead to left ventricular enlargement and eccentric left ventricular hypertrophy (112).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [112] source
Not checked in the free run.
- Premisecitation
Patients with chronic severe anemia under basal conditions showed increased forearm blood flow compared with control patients.
“they found that patients with chronic severe anemia under basal conditions showed increased forearm blood flow compared with control patients.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] source
Not checked in the free run.
- Premisecitation
The transcription factor Nrf2 is a redox switch regulating the expression of antioxidant enzymes, GSH-synthesizing enzymes, and detoxifying Phase 2 enzymes.
“The transcription factor Nrf2 is considered as a redox switch regulating the expression of antioxidant enzymes, GSH-synthesizing enzymes, and detoxifying Phase 2 enzymes (175), while the specific selenocysteine tRNA is needed for the synthesis of selenoproteins such as GPx or Trx reductase, which reduces oxidized Trx (133) (Fig. 2).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [175] source
Not checked in the free run.
- Premisecitation
The most frequent etiologies of anemia in elderly patients with CVD are nutritional deficiencies and chronic diseases, in particular renal insufficiency leading to EPO deficiency and chronic inflammation.
“In general, the most frequent etiologies of anemia in elderly patients with CVD are nutritional deficiencies (e.g., of iron, vitamin B12, and folic acid) and chronic diseases, in particular renal insufficiency [leading to EPO deficiency (56)] and chronic inflammation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] source
Not checked in the free run.
- Premisecitation
GPx4 KO mice show impaired hematopoiesis without hemolysis.
“GPx4 KO mice show impaired hematopoiesis without hemolysis (28), indicating that erythroid cells rather than adult RBCs are affected by deficient redox detoxification by GPx4.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] source
Not checked in the free run.
- Premisecitation
A pre-existing heart failure may be aggravated due to chronic anemia.
“In addition, a pre-existing heart failure may be aggravated due to chronic anemia (7, 93).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
A high percentage (almost 30%) of elderly patients with CVD exhibit idiopathic anemia.
“Moreover, a high percentage (almost 30%) of these patients exhibit idiopathic anemia (77) that may be caused by blood loss due to repetitive blood tests and surgical interventions, as well as occult bleeding (mainly in the gastrointestinal tract) during hospitalization.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] source
Not checked in the free run.
- Premisecitation
In hemolytic anemia, release of free Hb may lead to systemic NO scavenging, affecting vascular tone.
“For example, in hemolytic anemia, release of free Hb may lead to systemic NO scavenging, affecting vascular tone (71, 152).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisenone given
Isoform 4 of GPx (GPx4) is a mitochondrial enzyme important for detoxification of peroxides and H2O2 in mitochondria.
“Isoform 4 of GPx (GPx4) is a mitochondrial enzyme important for detoxification of peroxides and H2O2 in mitochondria.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Anemia leads to a persistent increase in cardiac workload to improve oxygen supply to organs and tissues.
“Taken together, anemia leads to a persistent increase in cardiac workload to improve oxygen supply to organs and tissues.”
Quote in the paperSubstantial claim - Interpretationreasoning
Changes in intrinsic properties of RBCs may contribute to the systemic effects observed in anemia.
“In addition to the well-known changes in cardiovascular hemodynamics in anemia, changes in intrinsic properties of RBCs may contribute to the systemic effects observed in anemia.”
Quote in the paperSubstantial claim - Premisecitation
The specific selenocysteine tRNA is needed for the synthesis of selenoproteins such as GPx or Trx reductase, which reduces oxidized Trx.
“The transcription factor Nrf2 is considered as a redox switch regulating the expression of antioxidant enzymes, GSH-synthesizing enzymes, and detoxifying Phase 2 enzymes (175), while the specific selenocysteine tRNA is needed for the synthesis of selenoproteins such as GPx or Trx reductase, which reduces oxidized Trx (133) (Fig. 2).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [133] source
Not checked in the free run.
- Interpretationcitation
Erythroid cells rather than adult RBCs are affected by deficient redox detoxification by GPx4.
“GPx4 KO mice show impaired hematopoiesis without hemolysis (28), indicating that erythroid cells rather than adult RBCs are affected by deficient redox detoxification by GPx4.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] source
Not checked in the free run.
- Interpretationreasoning
Intrinsic RBC dysfunction in anemia is not only a simple bystander/comorbidity of CVD but also significantly contributes to the appearance of severe complications and increased mortality as observed in the clinical setting.
“Therefore, we propose that intrinsic RBC dysfunction in anemia is not only a simple bystander/comorbidity of CVD but also significantly contributes to the appearance of severe complications and increased mortality as observed in the clinical setting.”
Quote in the paperNot a substantial claim - Premisecitation
Under anemic conditions, NO bioavailability may be increased by a decreased Hb-dependent inhibition of NO inactivation.
“After treatment with the NOS inhibitor, NG-monomethyl-L-arginine, a threefold greater decrease of blood flow was detected in anemic patients compared with healthy controls and it was proposed that under anemic conditions, NO bioavailability may be increased by a decreased Hb-dependent inhibition of NO inactivation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] source
Not checked in the free run.
- Premisecitation
After treatment with the NOS inhibitor NG-monomethyl-L-arginine, a threefold greater decrease of blood flow was detected in anemic patients compared with healthy controls.
“After treatment with the NOS inhibitor, NG-monomethyl-L-arginine, a threefold greater decrease of blood flow was detected in anemic patients compared with healthy controls and it was proposed that under anemic conditions, NO bioavailability may be increased by a decreased Hb-dependent inhibition of NO inactivation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] source
Not checked in the free run.
- Interpretationnone given
Loss of cell integrity and RBC dysfunction in anemia are intimately interconnected with regulation of blood viscosity, peripheral resistance, cardiac and vascular function, also via control of NO metabolism and redox regulation.
“In conclusion, loss of cell integrity and RBC dysfunction in anemia are intimately interconnected with regulation of blood viscosity, peripheral resistance, cardiac and vascular function, also via control of NO metabolism and redox regulation.”
Quote in the paperNot a substantial claim - Premisenone given
Receptors for EPO are found not only in erythroid cells but also in other cell types, including cardiomyocytes, vascular cells, and mature RBCs.
“It is important to consider that the receptors for EPO are found not only in erythroid cells but also in other cell types, including cardiomyocytes, vascular cells, and mature RBCs.”
Quote in the paperNot a substantial claim - Premisenone given
Storage of RBCs results in decreases in 2,3-diphosphoglycerate and ATP concentrations, which result in decreased O2 delivery.
“These changes include decreases in 2,3-diphosphoglycerate and ATP concentrations in stored RBCs, which result in decreased O2 delivery.”
Quote in the paperSubstantial claim - Premisecitation
Treatment with the Hb scavenger haptoglobin ameliorates vascular dysfunction and heme-driven oxidative reactions in guinea pigs.
“An experimental study in guinea pigs demonstrated that treatment with the Hb scavenger haptoglobin ameliorates vascular dysfunction and heme-driven oxidative reactions (9).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] source
Not checked in the free run.
- Interpretationreasoning
Adverse effects of transfusion might be due, in part, to a storage lesion of older RBC preparations, i.e., changes of biochemical and molecular characteristics of RBCs during their storage, resulting in membrane damage and impaired function of RBCs.
“This adverse effects of transfusion might be due, in part, to a storage lesion of older RBC preparations, i.e., changes of biochemical and molecular characteristics of RBCs during their storage, resulting in membrane damage and impaired function of RBCs.”
Quote in the paperSubstantial claim - Premisecitation
PS on the outer leaflet of RBCs is a target mediator of PLT activation, resulting in enhanced aggregation.
“In addition, PS on the outer leaflet of RBCs was identified to be a target mediator of PLT activation, resulting in enhanced aggregation (23).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] source
Not checked in the free run.
- Premisecitation
PS exposure on RBCs is increased in SCD.
“Notably, PS exposure on RBCs is increased in SCD (195).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [195] Wood BL, 1996, Blood source
Not checked in the free run.
- Interpretationcitation
Free Hb seems to be one of the major pathophysiological issues of transfusion.
“Free Hb seems to be one of the major pathophysiological issues of transfusion.”
Quote in the paperSubstantial claim - Premisecitation
Randomized clinical studies in patients with CVD demonstrate that EPO administration increases the mortality after cardiovascular events.
“Randomized clinical studies in patients with CVD demonstrate that EPO administration increases the mortality after cardiovascular events (143).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [143] source
Not checked in the free run.
- Interpretationcitation
The acute hemodynamic responses of EPO administration may result in impaired perfusion/oxygen supply to the tissues and contribute to acute adverse events such as enhanced PLT aggregation, thromboembolism, and myocardial ischemia.
“The acute hemodynamic responses of EPO administration may result in impaired perfusion/oxygen supply to the tissues and contribute to acute adverse events such as enhanced PLT aggregation, thromboembolism, and myocardial ischemia (17, 45).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
In hemolytic anemia, increased NO scavenging by free Hb might decrease NO availability and therefore increase PLT aggregation and thromboembolism.
“On the contrary, in hemolytic anemia, increased NO scavenging by free Hb might decrease NO availability and therefore increase PLT aggregation and thromboembolism.”
Quote in the paperSubstantial claim - Premisenone given
An estimated 10% of patients have inadequate responses to EPO or ESAs.
“An estimated 10% of patients have inadequate responses to EPO or ESAs.”
Quote in the paperNot a substantial claim - Premisecitation
NO is a potent inhibitor of PLT aggregation, acting via activation of soluble guanylyl cyclase in PLTs.
“NO is a potent inhibitor of PLT aggregation, acting via activation of soluble guanylyl cyclase in PLTs (64, 65).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
EPO has off-target effects, particularly in the heart and in the vessels.
“In fact, it was shown that EPO has off-target effects, particularly in the heart and in the vessels.”
Quote in the paperSubstantial claim - Premisecitation
Big cohort/epidemiological studies show associations between anemia and cardiovascular complications.
“Interestingly, there are big cohort/epidemiological studies showing associations between anemia and cardiovascular complications (48, 87, 91).”
Quote in the paperSubstantial claim0 of 3 sources checked
- Classified as probably not a substantial claim. 22
- May combine two claims. 89
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
FindingreasoningA single erythrocyte traverses the circulatory system in approximately 1 min, and during its average lifetime of 120 days undergoes on the order of 10^5 cycles of high flow conditions in the aorta followed by squeezing through capillaries.
“one can calculate that a single erythrocyte traverses the circulatory system in ∼1 min; therefore, during its average lifetime of 120 days (42), one RBC undergoes on the order of 105 cycles of high flow conditions in the aorta, followed by squeezing through the capillaries.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] David Shemin DR., 1946, J Biol Chem source
Not checked in the free run.
May combine two claims.
InterpretationcitationPMRS in RBCs may act as a compensatory mechanism against increased ROS/oxidative stress and represents a potential mechanism of how RBCs contribute to redox regulation throughout the whole body.
“Thus, PMRS in RBCs may act as a compensatory mechanism against increased ROS/oxidative stress and represents a potential mechanism of how RBCs contribute to redox regulation throughout the whole body (173).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [173] source
Not checked in the free run.
May combine two claims.
PremisecitationThese reactions lead to generation of the potent oxidizing ferrylHb species as well as secondary radicals from the reaction between H2O2 and either oxyHb or metHb.
“These reactions lead to generation of the potent oxidizing ferrylHb species as well as secondary radicals from the reaction between H2O2 and either oxyHb or metHb.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [150] source
Not checked in the free run.
May combine two claims.
PremisecitationAscorbate is involved in several antioxidant mechanisms such as reduction of diffusible oxidants and methemoglobin, as well as maintenance of the plasma membrane redox system.
“It is involved in several antioxidant mechanisms such as reduction of diffusible oxidants and metHb, as well as maintenance of plasma membrane redox system (PMRS) (51).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIncreased PMRS activity in erythrocytes during aging may be a protective mechanism for efficient extracellular dehydroascorbate reduction and ascorbate recycling under conditions of increased oxidative stress.
“The physiological significance of the PMRS is not completely understood, but it was reported that the increased PMRS activity in erythrocytes during aging may be a protective mechanism of the system for efficient extracellular dehydroascorbate reduction and ascorbate recycling under conditions of increased oxidative stress (173).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [173] source
Not checked in the free run.
May combine two claims.
Premisecitationα-Tocopherol accumulates in RBC membranes and plays a central role in preventing lipid peroxidation, probably by limiting the amplification of peroxidation chain reactions within the plasma membrane.
“Due to its lipophilicity, α-tocopherol accumulates in RBC membranes and plays a central role in preventing lipid peroxidation, probably by limiting the amplification of peroxidation chain reactions within the plasma membrane (24).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Brownlee NR, 1977, J Lipid Res source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe enzyme responsible for GSH recycling is glutathione reductase, which reduces glutathione disulfide back to reduced GSH via consumption of NADPH.
“The enzyme responsible for GSH recycling is glutathione reductase, which reduces glutathione disulfide (GSSG) back to the reduced GSH via consumption of NADPH (197).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [197] source
Not checked in the free run.
May combine two claims.
PremisecitationAscorbate is an essential hydrophilic vitamin and an important reducing equivalent in RBCs, which is (re)synthesized from dehydroascorbic acid at the expense of GSH in a reaction catalyzed by glutaredoxins.
“Ascorbate is an essential hydrophilic vitamin and an important reducing equivalent in RBCs, which is (re)synthesized from dehydroascorbic acid at the expense of GSH in a reaction catalyzed by a variety of enzymes, especially GRxs (190), which are small cytoplasmic enzymes also catalyzing deglutathionylation, reduction of protein disulfides, or Fe-S linkage formation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [190] Wells WW, 1990, J Biol Chem source
Not checked in the free run.
May combine two claims.
PremisecitationThe consequence of hemolysis is particularly evident in hemolytic anemia, where fragility of RBCs is mainly due to redox dysbalance or hemoglobinopathies, for example, sickle cell disease, and observed in transfusion of older blood.
“The consequence of hemolysis is particularly evident in hemolytic anemia, where fragility of RBCs is mainly due to redox dysbalance or hemoglobinopathies, for example, sickle cell disease (SCD) (see the section “RBC Dysfunction and Anemia” for more details), and observed in transfusion of older blood (71).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [71] source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
InterpretationreasoningRBC antioxidant pathways and their ability to reduce extracellular antioxidants via the transmembrane electron transport system, along with RBC mobility through the circulation, make them an ideal ROS buffering component, which may contribute to overall systemic homeostasis of redox balance.
“Beyond this, RBC antioxidant pathways and their ability to reduce extracellular antioxidants via the transmembrane electron transport system, along with RBC mobility through the circulation, make them an ideal ROS buffering component, which may contribute to overall systemic homeostasis of redox balance.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGSSG is recycled by GSH reductase, which consumes NADPH.
“GSSG is recycled by GSH reductase, which consumes NAPDH (38).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] source
Not checked in the free run.
May combine two claims.
PremisecitationDeoxyhemoglobin may be the only nitrite reductase of physiological relevance under hypoxic conditions, as inactivation of deoxyhemoglobin by treatment with carbon monoxide completely blocked NO release from RBCs as assessed by electron paramagnetic resonance.
“However, it was shown recently that deoxyhemoglobin may be the only nitrite reductase of physiological relevance under hypoxic conditions (Eq. 17) as inactivation of deoxyhemoglobin by treatment with carbon monoxide completely blocked NO release from RBCs as assessed by electron paramagnetic resonance (107).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [107] source
Not checked in the free run.
May combine two claims.
InterpretationreasoningRBCs induce NO synthesis in the vessel wall and thereby participate indirectly in maintenance of NO bioavailability.
“Thus, RBCs induce NO synthesis in the vessel wall and thereby participate indirectly in maintenance of NO bioavailability.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationChimera mice lacking eNOS in blood present a hypertensive phenotype along with decreased circulating nitrite and nitrate levels.
“these chimera mice present a hypertensive phenotype along with decreased circulating nitrite and nitrate levels (196)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [196] source
Not checked in the free run.
May combine two claims.
PremisecitationOther proposed nitrite reductases catalyzing NO formation from nitrite under hypoxic conditions are carbonic anhydrase, xanthine oxidase, or eNOS, which are all present in RBCs.
“Other proposed nitrite reductases catalyzing NO formation from nitrite under hypoxic conditions are carbonic anhydrase (1), xanthine oxidase (68), or eNOS (189), which are all present in RBCs.”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationNO can easily diffuse through plasma membranes, but its diffusion into RBCs is limited by transmembrane and intracellular resistances, as well as by the presence of an unstirred layer of solvent around the RBC.
“Thanks to its small size and lack of charge, NO can easily diffuse through plasma membranes, but its diffusion into the RBCs is limited by transmembrane and intracellular resistances (185), as well as by the presence of an unstirred layer of solvent around the RBC (extracellular resistance) (46).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Interpretationnone givenRBCs are particularly well equipped with potent nonenzymatic and enzymatic antioxidant systems, which are important to maintain hemoglobin in a reduced oxygen binding form, to limit oxidative modifications of membrane lipids, structural proteins, channels, and metabolic enzymes, and therefore to keep the cell alive and functional for its average 120-day life.
“To summarize, RBCs are particularly well equipped with potent nonenzymatic and enzymatic antioxidant systems, which are important to maintain Hb in a reduced oxygen binding form, to limit oxidative modifications of membrane lipids, structural proteins, channels, and metabolic enzymes, and therefore to keep the cell alive and functional for its (average) 120-day life.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationLoss of hemoglobin compartmentalization may lead to systemic NO scavenging and may affect endothelial function.
“Loss of Hb compartmentalization may lead to systemic NO scavenging and may affect endothelial function (72, 153).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationHigh concentrations of polyunsaturated fatty acids in RBC membrane make them susceptible to peroxidation leading to loss of RBC membrane integrity and decreased activity of membrane enzymes.
“High concentrations of polyunsaturated fatty acids in RBC membrane make them susceptible to peroxidation leading to the loss of RBC membrane integrity and decreased activity of membrane enzymes [e.g., ATPase (198) and acetylcholinesterase (183)].”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationHemoglobin may react with H2O2, promote ferrylHb formation, and induce lipid peroxidation.
“According to Eqs. 4–7, Hb may also react with H2O2 (e.g., generated during inflammatory conditions), promote ferrylHb formation, and induce lipid peroxidation (3).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] source
Not checked in the free run.
May combine two claims.
PremisecitationNOS in RBCs is a catalytically active eNOS (NOS3 type 1) identical to endothelial eNOS.
“Recently, the NOS in RBCs was identified as a catalytically active eNOS (NOS3 type 1), which is identical to the eNOS expressed in endothelium, as assessed by immunoprecipitation and liquid chromatography mass spectroscopy (40), and confirmed by others through the analysis of conversion of L-15N-arginine into L-15N-citrulline (52).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisereasoningDisorders of the RBC cytoskeleton lead to abnormal cell shapes such as spherocytosis and elliptocytosis, and the abnormal morphology and decreased surface area-to-volume ratio decrease deformability and ability to move through capillary beds and exchange gases.
“Disorders of the RBC cytoskeleton lead to changes in overall shape of the cells such as spherocytosis and elliptocytosis. The abnormal cellular morphology and decreased surface area-to-volume ratio in these disorders decrease deformability and the ability of cells to move through capillary beds and exchange gases.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningThe equilibrium of spectrin-actin interaction with transmembrane and membrane-associated proteins gives functional shape to RBC and allows elasticity.
“The equilibrium of spectrin–actin interaction along with transmembrane proteins (e.g., ion channels, receptors) and membrane-associated proteins (ankyrin, band 3, etc.) gives a functional shape to the RBC and allows for elasticity (i.e., reversible deformation) of the cell.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningHematocrit is the major determinant of blood viscosity; increased hematocrit increases blood viscosity.
“While hematocrit values are the major determinant of blood viscosity, as a more packed fluid (increased hematocrit) blood is more resistant to flow (increased viscosity)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenThe average internal volume of an RBC is 94 μm3 at 300 mOsmol/kg.
“The average internal volume of an RBC is 94 μm3 at 300 mOsmol/kg.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationLow concentrations of NO donors increase RBC deformability, membrane fluidity, and RBC filterability.
“while low concentrations of NO donors increase RBC deformability (22), membrane fluidity (181), and RBC filterability (99).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Premisenone givenBlood behaves as a shear-thinning non-Newtonian fluid during flow, so increased shear stress decreases blood viscosity.
“Blood instead behaves as a shear-thinning non-Newtonian fluid during flow so that increased shear stress on blood decreases blood viscosity (i.e., thinning of the liquid).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationNormal RBCs have several possible modes of changing shape, including elongation, end-over-end tumbling, periodic swinging, and membrane tanktreading.
“Normal RBCs have a few possible modes of changing their shape (114, 168, 188).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisereasoningThe discoid donut-like shape of RBCs is fundamental for their physiological function because it increases cell flexibility and creates a high surface area-to-volume ratio allowing efficient gas exchange.
“The discoid donut-like shape of RBCs is fundamental for their physiological function as it increases overall cell flexibility and creates a high cellular surface area-to-volume ratio allowing for efficient gas exchange.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCytoskeletal proteins (mainly spectrin, actin, band 3, and ankyrin) form a pseudohexagonal structure that creates a dynamic scaffold supporting integral membrane proteins and promoting cell integrity under constant stress.
“In RBCs, cytoskeletal proteins (mainly spectrin, actin, band 3, and ankyrin) form a pseudohexagonal structure. This structure creates a dynamic scaffold that supports integral membrane proteins and promotes integrity of the cells under constant stress (115).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [115] source
Not checked in the free run.
May combine two claims.
PremisecitationA small increase in plasma viscosity increases NO release by endothelium and can lead to decreased blood pressure.
“It was reported that a small increase in plasma viscosity (whether by increased hematocrit or non-O2-carrying dextran molecules) increases NO release by endothelium and can lead to decreased blood pressure (27, 119, 179).”
Quote in the paperNot a substantial claim0 of 3 sources checkedClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningRBCs play a central role in defining biophysics of blood rheology as well as efficiency of tissue perfusion and gas exchange.
“Being the major cellular component of blood, RBCs play a central role in defining biophysics of blood rheology as well as efficiency of tissue perfusion and gas exchange.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenErythropoiesis can be impaired by lack of substrates needed for Hb synthesis (e.g., iron) or cell division (e.g., vitamin B12 or folic acid), lack of EPO, or bone marrow disorders/aplasia.
“Erythropoiesis can be impaired due to a lack of substrates needed for Hb synthesis (e.g., iron) or for cell division (e.g., vitamin B12 or folic acid), lack of erythropoietin (EPO) to stimulate erythropoiesis, or due to bone marrow disorders/aplasia.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationRBC membrane flexibility depends on interactions of cytoskeletal proteins spectrin and actin and on intrinsic plasticity of the spectrin molecule.
“The flexibility of the RBC membrane depends on the interactions of cytoskeletal proteins, spectrin and actin (109), as well as on the intrinsic plasticity of the spectrin molecule which is due to its peculiar macromolecular structure (104).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenDecreases in circulating RBC numbers can be due to increased hemolysis or RBC depletion.
“Beyond that decreases in circulating RBC numbers can be due to increased hemolysis or RBC depletion (Fig. 6).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningAccumulating evidence indicates RBCs play an important role in control of systemic NO metabolism, transport, and release of vasoactive substances, participating in systemic control of cardiovascular function and cardioprotection.
“Taken together, there is accumulating evidence that RBCs play an important role in control of systemic NO metabolism, transport, and (as discussed in the RBC Mechanical Properties and Blood Rheology section) release of vasoactive substances, participating in systemic control of cardiovascular function and cardioprotection.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIncreased hemolysis may be caused by RBC dysfunction correlated with defects of Hb, cytoskeletal proteins, metabolic enzymes, redox dysregulation, antibodies against RBC surface antigens, chronic inflammation, drug/poisoning, other genetic defects, or RBC extrinsic factors.
“Increased hemolysis may be caused by dysfunction of RBCs correlated with (I) defects of Hb (hemoglobinopathies) (18, 94, 161, 199), including alterations in structure and function of Hb chains; (II) defects of cytoskeletal proteins such as spectrin and ankyrin, which are essential for maintaining cell shape and integrity (19, 134, 149, 169); (III) defects in metabolic enzymes catalyzing the pentos”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationA major source of ROS in sickle RBCs is autoxidation of sickle cell Hb and increase in NADPH oxidase activity.
“A major source of ROS in sickle RBCs is autoxidation of sickle cell Hb (80) and increase in NADPH oxidase activity (66).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenGenetic deficiency of G6PDH is one of the most common enzyme defects in humans leading to hemolytic anemia.
“One of the most common enzyme defects in humans is the deficiency of G6PDH.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThalassemic patients show altered deformability and increased rigidity and instability of RBCs.
“As in SCD, thalassemic patients show altered deformability as well as increased rigidity and instability of RBCs (166).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [166] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenAnkyrin connects the spectrin cytoskeleton to the RBC membrane, specifically to band 3.
“Ankyrin connects the spectrin cytoskeleton to the RBC membrane, specifically to band 3, a transmembrane anion exchanger channel.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenThe SCD mutation (Val6→Glu) causes the Hb tetramer to have different properties; the abnormal tetramer Hb S has decreased solubility in deoxygenated conditions and aggregates into long chains.
“This mutation (Val6→Glu) causes the Hb tetramer to have different properties. The abnormal tetramer (called Hb S) is characterized by decreased solubility in deoxygenated conditions, and aggregates form into long chains.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMost G6PDH-deficient patients are asymptomatic throughout their lifetime.
“Most G6PDH-deficient patients are asymptomatic throughout their lifetime and acute hemolytic anemia only occurs when triggered with certain drugs (antimalarial drugs such as primaquine), infections (hepatitis A virus), or pro-oxidative ingredients in food [e.g., fava beans, as already observed by the antiques (30)].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] source
Not checked in the free run.
May combine two claims.
PremisereasoningDeficiency of G6PDH induces a lack of reducing equivalents in RBCs and decreases activity of GSH reductase, which reduces GSSG to GSH.
“Deficiency of G6PDH induces a lack of reducing equivalents in RBCs and therefore decreases activity of GSH reductase, which reduces GSSG to GSH.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAccumulation of long Hb S chains in an RBC causes sickling, decreased deformability, and increased blood viscosity, resulting in peripheral vasoocclusion.
“Accumulation of the long Hb S chains in an RBC causes a change in the shape (sickling) of RBCs, decreased deformability, and increased blood viscosity (34), resulting in peripheral vasoocclusion, a painful symptom.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Chien S, 1970, Am J Physiol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenG6PDH is the enzyme that reduces NADP+ to NADPH as a branch of the glycolytic pathway.
“As described in the section “RBCs and Redox Regulation”, G6PDH is the enzyme that reduces NADP+ to NADPH as a branch of the glycolytic pathway.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationA consequence of sickling is increased RBC hemolysis, which releases Hb and other cytoplasmic proteins into the bloodstream, affecting plasma viscosity and colloid properties and increasing systemic NO scavenging.
“A further consequence of sickling of cells is increased RBC hemolysis. Hemolysis affects not only the number of circulating RBCs but also release of Hb (and other cytoplasmic proteins) within the blood stream, thus profoundly affecting the viscosity and colloid properties of plasma and increasing systemic NO scavenging (71, 152).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA disorder of cell distribution, for example because of hypersplenism, may lead to anemia.
“Moreover, a disorder of cell distribution (for example, because of hypersplenism) may lead to anemia (Table 1).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Table 1
Not checked in the free run.
May combine two claims.
PremisecitationOxidized, heme-depleted Hb forms precipitates (Heinz bodies), which accumulate within the cells, resulting in membrane rigidity and decreased RBC deformability.
“Oxidized, heme-depleted Hb forms precipitates (Heinz bodies), which accumulate within the cells, resulting in membrane rigidity and decreased RBC deformability (151).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [151] Reinhart WH, 1986, Blood source
Not checked in the free run.
May combine two claims.
PremisecitationSOD2 KO mice show severe RBC dysfunction and anemic phenotype characterized by decreased RBC deformability, increased heme degradation, and a reduced lifetime of RBCs.
“Although SOD2 is a mitochondrial enzyme and therefore existent in the RBC precursor cells only (118), SOD2 KO mice show severe RBC dysfunction and anemic phenotype characterized by decreased RBC deformability, increased heme degradation, and a reduced lifetime of RBCs (128).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [128] source
Not checked in the free run.
May combine two claims.
PremisecitationDeficiency of ankyrin in RBCs results in disruption of cytoskeletal formation, spherocytosis, and markedly increased mortality.
“Deficiency of ankyrin in RBCs results in disruption of cytoskeletal formation, spherocytosis, and markedly increased mortality (149).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [149] source
Not checked in the free run.
May combine two claims.
PremisecitationRedox dysregulation in RBCs leads to membrane protein thiol oxidation and membrane damage, as well as oxidative damage of proteins, including Hb and cytoskeletal proteins in the spectrin-actin network.
“Redox dysregulation in RBCs leads to membrane protein thiol oxidation and membrane damage, as well as oxidative damage of proteins, including Hb and cytoskeletal proteins in the spectrin–actin network (90).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [90] Johnson RM, 1994, Blood source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenThalassemia is an autosomal recessive group of genetic diseases resulting from defects in synthesis/structural properties of Hb subunits.
“Thalassemia is another autosomal recessive group of genetic diseases resulting from defects in synthesis/structural properties of Hb subunits.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSCD is caused by a point mutation in the β Hb subunit chain and shows multiple clinical manifestations and early mortality, particularly if the individual is homozygous for the mutation or untreated.
“SCD is caused by a point mutation in the β Hb subunit chain and shows multiple clinical manifestations and early mortality, particularly if the individual is homozygous for the mutation or untreated (80).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] source
Not checked in the free run.
May combine two claims.
PremisecitationMice with a deficiency of Prx2 have decreased hematocrit levels and an increased amount of circulating reticulocytes.
“Mice with a deficiency of Prx2, the more abundant peroxiredoxin in RBCs, have decreased hematocrit levels and an increased amount of circulating reticulocytes (106).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [106] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationG6PDH deficiency is one of the most common enzyme defects in humans due to multiple mutations of the G6PDH gene.
“G6PDH deficiency is one of the most common enzyme defects in humans due to multiple mutations of the G6PDH gene and imparts different phenotypes, from acute hemolytic anemia to chronic hemolysis (30).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] source
Not checked in the free run.
May combine two claims.
PremisecitationAn excess of one Hb subunit leads to denaturation of the excessive globin chain followed by formation of inclusion bodies.
“An excess of one subunit leads to denaturation of the excessive globin chain (165), followed by the formation of inclusion bodies (57).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [165] Shinar E, 1990, Semin Hematol
Not checked in the free run.
- cites [57] Fessas P., 1963, Blood source
Not checked in the free run.
May combine two claims.
PremisereasoningAnemia conditions due to RBC dysfunction induced by genetic defects include hemoglobinopathies such as SCD and thalassemia, defects of cytoskeletal proteins, and redox dysregulation leading to hemolytic anemia.
“These include (I) hemoglobinopathies, such as SCD, and thalassemia, which are well-described human genetic defects; (II) defects of cytoskeletal proteins, mainly described in transgenic mice; and (III) redox dysregulation related to genetic defects leading to increased production of oxidants and/or decreased antioxidant capacity, which ultimately lead to hemolytic anemia.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSOD2 is a mitochondrial enzyme and therefore existent in the RBC precursor cells only.
“Although SOD2 is a mitochondrial enzyme and therefore existent in the RBC precursor cells only (118), SOD2 KO mice show severe RBC dysfunction and anemic phenotype characterized by decreased RBC deformability, increased heme degradation, and a reduced lifetime of RBCs (128).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [118] source
Not checked in the free run.
May combine two claims.
PremisecitationAdministration of hydroxyurea induces expression of HbF, which interferes with polymerization of HbS.
“Administration of hydroxyurea has been shown to induce expression of HbF, which interferes with the polymerization of HbS (33).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] source
Not checked in the free run.
May combine two claims.
PremisecitationErythroid cell-specific knockout mice of band 3 have changes in cell geometry and decreased cellular surface area-to-volume ratio, implying membrane/cytoskeleton interactions play a central role in defining RBC shape and functionality.
“Erythroid cell-specific knockout (KO) mice of band 3 induce changes in cell geometry, decreasing the cellular surface area-to-volume ratio, implying that the membrane/cytoskeleton interactions play a central role in defining RBC shape and functionality (169).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [169] source
Not checked in the free run.
May combine two claims.
PremisecitationMice lacking the SOD1 gene show increased levels of ROS, decreased life span, increased reticulocyte counts, and increased levels of Heinz bodies, but overall display a comparatively benign anemia and no changes in intracellular GSH levels.
“Mice lacking the SOD1 gene show increased levels of ROS, decreased life span, increased reticulocyte counts, and increased levels of Heinz bodies, but overall these mice display a comparatively benign anemia and no changes in intracellular GSH levels (76).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [76] source
Not checked in the free run.
May combine two claims.
PremisecitationIn β-thalassemic mice, heme degradation products are increased 3.5-fold, suggesting a less efficient antioxidant system within RBCs.
“Nagababu et al. (137) determined a 3.5-fold increase in heme degradation products in β-thalassemic mice and propose a less efficient antioxidant system within RBCs.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [137] source
Not checked in the free run.
May combine two claims.
PremisecitationRBC dysfunction leading to anemia may be due to defects in cytoskeletal proteins, as demonstrated by transgenic mouse models lacking cytoskeletal proteins.
“RBC dysfunction leading to anemia may be also due to defects in cytoskeletal proteins (115, 127), as demonstrated by numerous transgenic mouse models lacking cytoskeletal proteins (see Fig. 3 for description of the cytoskeleton) (134).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationNrf2 KO mice and Trsp KO mice are not anemic; but hemolytic anemia can be induced by treatment with oxidant drugs.
“Nrf2 KO mice and Trsp KO mice are not anemic; but hemolytic anemia can be induced by treatment with oxidant drugs (54).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] source
Not checked in the free run.
May combine two claims.
PremisecitationThere is accumulating evidence that anemia is related to a series of severe complications in CVD such as thromboembolic events, bleeding complications, uncontrolled hypertension, more frequent supraventricular and ventricular arrhythmias, and inflammation characterized by elevated levels of inflammatory cytokines.
“There is accumulating evidence that anemia is related to a series of severe complications in CVD such as thromboembolic events (e.g., venous thrombosis and stroke), bleeding complications (191), uncontrolled hypertension (117), more frequent supraventricular and ventricular arrhythmias, and inflammation characterized by elevated levels of inflammatory cytokines (170).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [170] source
Not checked in the free run.
May combine two claims.
PremisecitationElderly patients aged 65 years and older have a 10% higher risk for the development of anemia, which increases to 20% in those aged 85 years and older.
“There is compelling evidence that elderly patients—aged 65 years and older—have a 10% higher risk for the development of anemia, which increases to 20% in those aged 85 years and older (77).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] source
Not checked in the free run.
May combine two claims.
InterpretationcitationA decrease in blood viscosity may reduce endothelial-derived NO production and decrease NO bioavailability.
“Effects of blood viscosity on shear stress-induced activation of eNOS in the endothelium were also proposed (119); therefore, a decrease in blood viscosity may also reduce endothelial-derived NO production and decrease NO bioavailability.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [119] source
Not checked in the free run.
May combine two claims.
PremisecitationDecrease in viscosity of blood reduces systemic vascular resistance and affects cardiovascular hemodynamics.
“Decrease in viscosity of blood reduces systemic vascular resistance and affects cardiovascular hemodynamics (20).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] source
Not checked in the free run.
May combine two claims.
PremisecitationAnemia is a frequent comorbidity in CVD and is associated with higher mortality as well as increased hospitalization after myocardial infarction, even under mild anemic conditions.
“Anemia is a frequent comorbidity in CVD (48) and is associated with higher mortality as well as increased hospitalization after myocardial infarction (91), even under mild anemic conditions (13, 156).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationIn anemic conditions where the number of circulating RBCs is decreased without concomitant hemolysis, a decrease of RBC-dependent scavenging of NO may increase systemic NO bioavailability and cause vasodilation, increased flow, and may affect cardiovascular hemodynamics.
“On the contrary, in anemic conditions where the number of circulating RBCs is decreased without concomitant hemolysis, a decrease of RBC-dependent scavenging of NO may instead increase systemic NO bioavailability and cause vasodilation, increased flow, and may affect cardiovascular hemodynamics (140).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [140] source
Not checked in the free run.
May combine two claims.
PremisecitationMyelodysplastic syndrome was proposed to be a frequent cause of idiopathic anemia; however, myelodysplastic syndrome is a rare disease, which mostly emerges initially in elderly patients who display alterations in blood cell counts.
“Moreover, the myelodysplastic syndrome (also defined as aplastic anemia) was proposed to be a frequent cause of idiopathic anemia (77); however, myelodysplastic syndrome is a rare disease, which mostly emerges initially in elderly patients who display alterations in blood cell counts (135).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationBlood loss in healthy dogs increased heart rate, stroke volume, and cardiac output and decreased mean arterial pressure and systemic vascular resistance.
“They showed that blood loss in healthy dogs increased heart rate, stroke volume, and cardiac output and decreased mean arterial pressure and systemic vascular resistance.”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
InterpretationreasoningThis persistent increase in cardiac work may induce progressive damage of cardiomyocytes, possibly leading to cardiac remodeling and to impairment of myocardial performance.
“This persistent increase in cardiac work may induce progressive damage of cardiomyocytes, possibly leading to cardiac remodeling and to impairment of myocardial performance.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAnemia significantly affects tissue perfusion and oxygenation mainly via a decreased O2-carrying capacity of the blood and a change in the apparent viscosity of blood because of a decrease in the RBC number/concentration.
“According to the classical view, anemia significantly affects tissue perfusion and oxygenation mainly via a decreased O2-carrying capacity of the blood (due to decreased Hb concentrations) and a change in the apparent viscosity of blood because of a decrease in the RBC number/concentration (78).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] GuytonAC and HallJE. Textbook of Medical Physiology. Philadelphia: Elsevier Saunders, 2006, xxxv, p. 1116.
Not checked in the free run.
May combine two claims.
InterpretationcitationIdiopathic anemia in these patients may be caused by blood loss due to repetitive blood tests and surgical interventions, as well as occult bleeding during hospitalization.
“Moreover, a high percentage (almost 30%) of these patients exhibit idiopathic anemia (77) that may be caused by blood loss due to repetitive blood tests and surgical interventions, as well as occult bleeding (mainly in the gastrointestinal tract) during hospitalization.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] source
Not checked in the free run.
May combine two claims.
PremisecitationActivation of Nrf2 decreased production of inflammatory cytokines and decreased the number of irregularly shaped erythrocytes in SCD.
“Activation of Nrf2 was proposed to be a potential therapeutic target for the treatment of SCD and its activation decreased production of inflammatory cytokines and decreased the number of irregularly shaped erythrocytes (16).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16]
Not checked in the free run.
May combine two claims.
InterpretationreasoningThese changes are mainly due to increased preload, decreased afterload, and changes in cardiac geometry so that left ventricular systolic dysfunction may develop over time in patients without CVD.
“These changes are mainly due to increased preload, decreased afterload, and changes in cardiac geometry so that left ventricular systolic dysfunction may develop over time in patients without CVD.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationIncrease in NO bioavailability would increase cardiac output and thereby affect cardiovascular hemodynamics.
“They proposed that increase in NO bioavailability would increase cardiac output and thereby affect cardiovascular hemodynamics.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] source
Not checked in the free run.
May combine two claims.
PremisecitationAnemic patients and patients with coronary artery disease exhibit an elevated risk of major bleeding during hospitalization.
“Increasing evidence exists that anemic patients and patients with coronary artery disease exhibit an elevated risk of major bleeding during hospitalization (48, 132, 174).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationNrf2/Trsp double-KO mice show a massive increase in ROS and severe anemia.
“In contrast, Nrf2/Trsp double-KO mice show a massive increase in ROS and severe anemia (95).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] source
Not checked in the free run.
May combine two claims.
PremisecitationStored RBCs release membrane fragments, or microparticles, containing Hb, which are able to scavenge NO and decrease endothelial function.
“More recently, it was shown that stored RBCs release membrane fragments, or microparticles, containing Hb, which are able to scavenge NO and decrease endothelial function (153).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [153] source
Not checked in the free run.
May combine two claims.
PremisecitationPLTs can be activated via pharmacological inhibition of endogenous NO production in humans, leading to hypercoagulability and thrombotic complications.
“Experimental studies demonstrated that PLTs can be activated via pharmacological inhibition of endogenous NO production in humans (159), leading to hypercoagulability and thrombotic complications (186).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationThe risk of thromboembolism is elevated after transfusion of packed/damaged RBCs, which correlates with impaired outcome and survival of patients.
“Furthermore, the risk of thromboembolism is elevated after transfusion of packed/damaged RBCs, which correlates with impaired outcome and survival of patients (47).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] source
Not checked in the free run.
May combine two claims.
PremisecitationEPO therapy can only be effective if the EPO responsiveness in the bone marrow is still intact, EPO is not removed from the circulation, or if EPO can reach its receptor on the bone marrow and if the receptors and signaling pathways downstream can be activated.
“EPO therapy can only be effective if the EPO responsivness in the bone marrow is still intact, EPO is not removed from the circulation (via receptor-mediated endocytosis, followed by degradation in lysosomes) (74), or if EPO can reach its receptor on the bone marrow and if the receptors and signaling pathways downstream can be activated.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [74] source
Not checked in the free run.
May combine two claims.
PremisecitationPatients with CVD, treated acutely by blood transfusion, have a worsened outcome and show adverse events such as thromboembolism, allergic reactions, and fever, in addition to acute hemodynamic changes.
“However, there is compelling evidence that patients with CVD, treated acutely by blood transfusion, have a worsened outcome and show adverse events such as thromboembolism, allergic reactions, and fever, in addition to acute hemodynamic changes (such as elevated blood pressure and increased total blood volume and left ventricular work) (158).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [158] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Premisenone given20%-30% of patients with CVD have concomitant anemia and anemia itself may contribute to clinical complications and death.
“In particular, one challenge is that 20%–30% of patients with CVD have concomitant anemia and that anemia itself may contribute to clinical complications and death.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationElevated oxidative stress can be found in PLTs when incubated with thalassemic RBCs compared with normal RBCs, leading to increased PLT activation.
“In particular, experimental studies indicate that elevated oxidative stress can be found in PLTs when incubated with thalassemic RBCs compared with normal RBCs, leading to increased PLT activation (5).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Amer J, 2004, Thromb Haemost source
Not checked in the free run.
May combine two claims.
InterpretationreasoningTransfusion of older blood may profoundly affect cardiovascular hemodynamics and increase mortality by decreasing NO bioavailability.
“These findings imply that transfusion of older blood may profoundly affect cardiovascular hemodynamics and increase mortality by decreasing NO bioavailability.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAdministration of EPO under nonanemic conditions protects cardiomyocytes against ischemic injury in vitro, limits infarct size, and improves myocardial function after I/R injury.
“However, experimental studies showed that administration of EPO under nonanemic conditions protects cardiomyocytes against ischemic injury in vitro, limits infarct size, and improves myocardial function after I/R injury (145).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [145] source
Not checked in the free run.
May combine two claims.
Interpretationnone givenClinical and experimental evidence reveals a complex role for RBCs in homeostasis and thrombosis, implicating RBC-PLT interactions, which involve membrane adhesion molecules, NO metabolism, and redox equilibria.
“Taken together, clinical and experimental evidence reveals a complex role for RBCs in homeostasis and thrombosis, implicating RBC-PLT interactions, which involve membrane adhesion molecules, NO metabolism, and redox equilibria.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenAltered NO metabolism and NO scavenging by transfusion of damaged RBCs was proposed to play a role in cardiovascular effects of older blood, but alteration of other noncanonical functions of RBCs, including redox dysregulation and mechanical properties, may be involved in these effects.
“Altered NO metabolism and NO scavenging by transfusion of damaged RBCs was proposed to play a role in cardiovascular effects of older blood, but alteration of other noncanonical functions of RBCs, including redox dysregulation and mechanical properties, may be involved in these effects.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenAnemia is characterized by multiple etiologies, phenotype of circulating RBCs, and pathophysiological outcome.
“Despite its simple definition, anemia is characterized by multiple etiologies, phenotype of circulating RBCs, and pathophysiological outcome.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPLTs and RBCs from patients with different types of anemia such as SCD, β-thalassemia, and myelodysplastic syndrome show a dysregulation of redox systems and altered PLT-RBC interactions.
“There is compelling evidence that PLTs and RBCs from patients with different types of anemia such as SCD, β-thalassemia, and myelodysplastic syndrome show a dysregulation of redox systems (5, 6, 69) and altered PLT-RBC interactions.”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationEPO administration to normovolemic anemic patients increased systemic vascular resistance and arterial blood pressure and decreased cardiac output due to diminished heart rate and venous return.
“Indeed, it was shown that EPO administration to normovolemic anemic patients increased systemic vascular resistance and arterial blood pressure and decreased cardiac output due to diminished heart rate and venous return (103, 194).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationAccording to basic science studies, RBCs may control systemic hemodynamics by influencing blood rheological properties and contribute to tissue protection and cardiovascular homeostasis.
“Additionally, according to basic science studies, RBCs may control systemic hemodynamics by influencing blood rheological properties and contribute to tissue protection and cardiovascular homeostasis (40, 73, 82).”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenThe therapeutic approaches currently applied in clinical practice do not appear to be beneficial for these patients and, in some cases such as in transfusion of stored blood, may increase risk of mortality.
“The therapeutic approaches currently applied in clinical practice not appear to be beneficial for these patients and, in some cases such as in transfusion of stored blood, may increase risk of mortality.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningStorage of RBCs may affect noncanonical function of RBCs, leading to decreased RBC deformability, impaired redox regulation, decrease of NO metabolites and increased membrane fragility, and thus to hemolysis and release of free Hb.
“In addition, storage of RBCs may affect also noncanonical function of RBCs, leading to decreased RBC deformability, impaired redox regulation, decrease of NO metabolites and increased membrane fragility, and thus to hemolysis and release of free Hb.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationA negative correlation between Hb levels and inflammatory markers was found in poor EPO responders, indicating that the severity of anemia correlates with the state of inflammation.
“Moreover, a negative correlation between Hb levels and inflammatory markers was found in poor EPO responders, indicating that the severity of anemia correlates with the state of inflammation (176).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [176] Taniguchi S, 1997, Blood source
Not checked in the free run.
May combine two claims.
Premisenone givenIn case of repeated blood transfusions, additional transfusion-related complications arise, including acute lung injury, electrolyte disorders, and iron overload.
“In case of repeated blood transfusions, additional transfusion-related complications arise, including acute lung injury, electrolyte disorders (hyperkalemia and hypocalcemia), and iron overload.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenWhile effects of blood loss may be strictly linked to effects of decreased RBC count and volume, the pathological consequences of hemolytic anemia may be related more closely to massive release of Hb in the circulation and its NO-scavenging properties.
“For example, while effects of blood loss may be strictly linked to effects of decreased RBC count and volume, the pathological consequences of hemolytic anemia (which is mainly linked to a dysregulation of redox homeostasis or to hemoglobinopathies) may be related more closely to massive release of Hb in the circulation and its NO-scavenging properties.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Anemia is associated with severe complications of cardiovascular disease such as bleeding, thromboembolic events, stroke, hypertension, arrhythmias, and inflammation, particularly in elderly patients.
“Recent clinical evidence identified anemia to be correlated with severe complications of cardiovascular disease (CVD) such as bleeding, thromboembolic events, stroke, hypertension, arrhythmias, and inflammation, particularly in elderly patients.”
The paper relies on this without support.
The underlying mechanisms of the cardiovascular complications associated with anemia are largely unidentified.
“The underlying mechanisms of these complications are largely unidentified.”
The paper relies on this without support.
The mechanistic links between changes of RBC functional properties and cardiovascular complications related to anemia have not been untangled so far.
“The mechanistic links between changes of RBC functional properties and cardiovascular complications related to anemia have not been untangled so far.”
The paper relies on this without support.
Many aspects of RBC-mediated control of NO metabolism and ATP release are still speculative or not universally accepted.
“However, many aspects of RBC-mediated control of NO metabolism and ATP release are still speculative or not universally accepted.”
The paper relies on this without support.
RBCs have limited capacity to restore damaged elements due to loss of protein expression during erythropoietic maturation.
“third, RBCs have limited capacity to restore damaged elements due to loss of protein expression during erythropoietic maturation.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Lipoxygenases catalyze the insertion of oxygen in polyunsaturated fatty acids.
“Lipoxygenases catalyze the insertion of oxygen in polyunsaturated fatty acids (119, 535, 1040) and are also biological sources of superoxide (537).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [535]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Cytoskeleton discussion points to the NO-metabolism figure
MinorThe cytoskeleton discussion directs readers to Fig. 3, but the paper identifies Fig. 3 as its illustration of NO metabolism. Fig. 4 is the figure that describes the RBC cytoskeleton.
“see Fig. 3 for description of the cytoskeleton”
“Figure: FIG. 3. Role of RBCs in systemic NO metabolism.”
Figure calls motions deformations that the text says do not change cell shape
MinorThe Fig. 4 caption presents four modes, including swinging and tumbling, as ways an RBC can deform. The accompanying text explicitly says those two modes are not changes in shape for an individual RBC.
“There are four distinct ways that RBCs can deform while traveling in the bloodstream.”
“Other modes of motion in response to changes in flow are also end-over-end tumbling and periodic swinging (Fig. 4), which are not changes in shape for an individual RBC”
Cites
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952 · see citing works
Flow-mediated endothelial mechanotransduction
Davies, P. F. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.519 · Cited by 2,802 · see citing works
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340 · cited 1× · see citing works
“Hydroxyurea is a cytostatic drug also applied in the therapy of SCD. Administration of hydroxy-urea has been shown to induce expression of HbF, which interferes with the polymerization of HbS (33).”
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930 · see citing works
Glucose-6-phosphate dehydrogenase deficiency
Cappellini, M., & Fiorelli, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60073-2 · Cited by 1,590 · see citing works
Guralnik, J. M., Eisenstaedt, R. S., Ferrucci, L., Klein, H. G., & Woodman, R. C. (2004) · Blood · doi:10.1182/blood-2004-05-1812 · Cited by 1,450 · see citing works
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330 · see citing works
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097 · see citing works
Red cell membrane: past, present, and future
Mohandas, N., & Gallagher, P. G. (2008) · Blood · doi:10.1182/blood-2008-07-161166 · Cited by 1,089 · see citing works
Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
Subherwal, S., Bach, R. G., Chen, A. Y., Gage, B. F., Rao, S. V., Newby, L. K., Wang, T. Y., Gibler, W. B., Ohman, E. M., Roe, M. T., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.828541 · Cited by 1,007 · see citing works
Molecular basis of the Keap1–Nrf2 system
Suzuki, T., & Yamamoto, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.006 · Cited by 995 · see citing works
Sessa, W. C., Pritchard, K., Seyedi, N., Wang, J., & Hintze, T. H. (1994) · Circulation Research · doi:10.1161/01.res.74.2.349 · Cited by 934 · cited 1× · see citing works
“One important activator of production of NO in the endothelium is shear stress (43, 163).”
Moscucci, M. M. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00485-8 · Cited by 919 · see citing works
Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression
Neumann, C. A., Krause, D. S., Carman, C. V., Das, S., Dubey, D. P., Abraham, J. L., Bronson, R. T., Fujiwara, Y., Orkin, S. H., & Van Etten, R. A. (2003) · Nature · doi:10.1038/nature01819 · Cited by 801 · see citing works
Enomoto, A. (2001) · Toxicological Sciences · doi:10.1093/toxsci/59.1.169 · Cited by 728 · see citing works
Cohen, G., & Hochstein, P. (1963) · Biochemistry · doi:10.1021/bi00906a038 · Cited by 666 · see citing works
ZITKA, O., SKALICKOVA, S., GUMULEC, J., MASARIK, M., ADAM, V., HUBALEK, J., TRNKOVA, L., KRUSEOVA, J., ECKSCHLAGER, T., & KIZEK, R. (2012) · Oncology Letters · doi:10.3892/ol.2012.931 · Cited by 664 · see citing works
Nitrate and nitrite in biology, nutrition and therapeutics
Lundberg, J. O., Gladwin, M. T., Ahluwalia, A., Benjamin, N., Bryan, N. S., Butler, A., Cabrales, P., Fago, A., Feelisch, M., Ford, P. C., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.260 · Cited by 617 · see citing works
Self-citationRed blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging
Mohanty, J. G., Nagababu, E., & Rifkind, J. M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00084 · Cited by 595 · see citing works
Export by red blood cells of nitric oxide bioactivity
Pawloski, J. R., Hess, D. T., & Stamler, J. S. (2001) · Nature · doi:10.1038/35054560 · Cited by 579 · see citing works
Red blood cells express a functional endothelial nitric oxide synthase
Kleinbongard, P. (2005) · Blood · doi:10.1182/blood-2005-10-3992 · Cited by 566 · see citing works
A novel protective effect of erythropoietin in the infarcted heart
Parsa, C. J., Matsumoto, A., Kim, J. H., Riel, R. U., Pascal, L. S., Walton, G. B., Thompson, R. B., Petrofski, J. A., Annex, B. H., Stamler, J. S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18200 · Cited by 543 · see citing works
Diffusion-limited reaction of free nitric oxide with erythrocytes
Liu, X., Miller, M. J. S., Joshi, M. S., Sadowska-Krowicka, H., Clark, D. A., & Lancaster, J. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18709 · Cited by 512 · see citing works
Wells, W. W., Xu, D. P., Yang, Y., & Rocque, P. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55401-6 · Cited by 450 · see citing works
Wood, B., Gibson, D., & Tait, J. (1996) · Blood · doi:10.1182/blood.v88.5.1873.1873 · Cited by 445 · see citing works
Gladwin, M. T., Shelhamer, J. H., Schechter, A. N., Pease-Fye, M. E., Waclawiw, M. A., Panza, J. A., Ognibene, F. P., & Cannon, R. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11482 · Cited by 441 · see citing works
Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice
Lee, T.-H. (2003) · Blood · doi:10.1182/blood-2002-08-2548 · Cited by 420 · see citing works
Exchange of Heme among Hemoglobins and between Hemoglobin and Albumin
Bunn, H. F., & Jandl, J. H. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93628-8 · Cited by 415 · see citing works
Visualization of the hexagonal lattice in the erythrocyte membrane skeleton.
Liu, S. C., Derick, L. H., & Palek, J. (1987) · The Journal of Cell Biology · doi:10.1083/jcb.104.3.527 · Cited by 408 · see citing works
Influence of reduced red cell deformability on regional blood flow
Simchon, S., Jan, K. M., & Chien, S. (1987) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1987.253.4.h898 · Cited by 389 · see citing works
THE LIFE SPAN OF THE HUMAN RED BLOOD CELL
Shemin, D., & Rittenberg, D. (1946) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35201-8 · Cited by 389 · see citing works
Villagra, J., Shiva, S., Hunter, L. A., Machado, R. F., Gladwin, M. T., & Kato, G. J. (2007) · Blood · doi:10.1182/blood-2006-12-061697 · Cited by 384 · see citing works
Forced Unfolding of Proteins Within Cells
Johnson, C. P., Tang, H., Krieger, C. C., Speicher, D. W., & Discher, D. E. (2007) · Science · doi:10.1126/science.1139857 · Cited by 377 · see citing works
Anatomy of the red cell membrane skeleton: unanswered questions
Lux, S. E. (2015) · Blood · doi:10.1182/blood-2014-12-512772 · Cited by 373 · see citing works
Erythrocytes are the major intravascular storage sites of nitrite in human blood
Dejam, A. (2005) · Blood · doi:10.1182/blood-2005-02-0567 · Cited by 350 · see citing works
Reduced Erythrocyte Deformability in Diabetes
McMillan, D. E., Utterback, N. G., & Puma, J. L. (1978) · Diabetes · doi:10.2337/diab.27.9.895 · Cited by 347 · see citing works
Recombinant Human Erythropoietin for Patients with AIDS Treated with Zidovudine
Fischl, M. A., Galpin, J. E., Levine, J. D., Groopman, J. E., Henry, D. H., Kennedy, P., Miles, S. A., Robbins, W., Starrett, B., Zalusky, R., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005243222103 · Cited by 336 · see citing works
Morris, C. R., Morris, S. M., Hagar, W., van Warmerdam, J., Claster, S., Kepka‐Lenhart, D., Machado, L., Kuypers, F. A., & Vichinsky, E. P. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-967oc · Cited by 328 · see citing works
Lipid peroxidation in erythrocytes
Clemens, M. R., & Waller, H. D. (1987) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(87)90068-5 · Cited by 318 · see citing works
Protection and Recycling of α-Tocopherol in Human Erythrocytes by Intracellular Ascorbic Acid
May, J. M., Qu, Z.-C., & Mendiratta, S. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0473 · Cited by 316 · see citing works
Effects of nitric oxide on red blood cell deformability
Bor-Kucukatay, M., Wenby, R. B., Meiselman, H. J., & Baskurt, O. K. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00665.2002 · Cited by 309 · see citing works
Endothelial cell expression of haemoglobin α regulates nitric oxide signalling
Straub, A. C., Lohman, A. W., Billaud, M., Johnstone, S. R., Dwyer, S. T., Lee, M. Y., Bortz, P. S., Best, A. K., Columbus, L., Gaston, B., et al. (2012) · Nature · doi:10.1038/nature11626 · Cited by 308 · see citing works
Self-citationKautz, L., Jung, G., Du, X., Gabayan, V., Chapman, J., Nasoff, M., Nemeth, E., & Ganz, T. (2015) · Blood · doi:10.1182/blood-2015-07-658419 · Cited by 306 · see citing works
Accelerated autoxidation and heme loss due to instability of sickle hemoglobin.
Hebbel, R. P., Morgan, W. T., Eaton, J. W., & Hedlund, B. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.1.237 · Cited by 306 · see citing works
Extracellular hemin crisis triggers acute chest syndrome in sickle mice
Ghosh, S., Adisa, O. A., Chappa, P., Tan, F., Jackson, K. A., Archer, D. R., & Ofori-Acquah, S. F. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64578 · Cited by 282 · see citing works
Baek, J. H., D’Agnillo, F., Vallelian, F., Pereira, C. P., Williams, M. C., Jia, Y., Schaer, D. J., & Buehler, P. W. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59770 · Cited by 280 · see citing works
Tilney, L. G., & Detmers, P. (1975) · The Journal of cell biology · doi:10.1083/jcb.66.3.508 · Cited by 258 · see citing works
Malarial anemia: of mice and men
Lamikanra, A., Brown, D., Potocnik, A. J., Casals‐Pascual, C., Langhorne, J., & Roberts, D. J. (2007) · Blood · doi:10.1182/blood-2006-09-018069 · Cited by 255 · see citing works
Faris, P. M., Ritter, M. A., & Abels, R. I. (1996) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199601000-00009 · Cited by 251 · see citing works
Glutathione peroxidase 4 prevents necroptosis in mouse erythroid precursors
Canli, Ö., Alankuş, Y. B., Grootjans, S., Vegi, N., Hültner, L., Hoppe, P. S., Schroeder, T., Vandenabeele, P., Bornkamm, G. W., & Greten, F. R. (2016) · Blood · doi:10.1182/blood-2015-06-654194 · Cited by 247 · see citing works
Redox Reactions of Hemoglobin and Myoglobin: Biological and Toxicological Implications
Alayash, A. I., Patel, R. P., & Cashon, R. E. (2001) · Antioxidants & Redox Signaling · doi:10.1089/152308601300185250 · Cited by 243 · see citing works
Erythrocyte Glut1 Triggers Dehydroascorbic Acid Uptake in Mammals Unable to Synthesize Vitamin C
Montel-Hagen, A., Kinet, S., Manel, N., Mongellaz, C., Prohaska, R., Battini, J.-L., Delaunay, J., Sitbon, M., & Taylor, N. (2008) · Cell · doi:10.1016/j.cell.2008.01.042 · Cited by 243 · see citing works
Oxidation induces a Cl<sup>−</sup>‐dependent cation conductance in human red blood cells
Duranton, C., Huber, S. M., & Lang, F. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013040 · Cited by 233 · see citing works
Left ventricular alterations and end‐stage renal disease
London, G. M. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_1.29 · Cited by 229 · see citing works
Erythrocytes Possess an Intrinsic Barrier to Nitric Oxide Consumption
Vaughn, M. W., Huang, K., Kuo, L., & Liao, J. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2342 · Cited by 220 · see citing works
Amer, J., Ghoti, H., Rachmilewitz, E. A., Koren, A., Levin, C., & Fibach, E. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05834.x · Cited by 219 · see citing works
Ghosh, S. M., Kapil, V., Fuentes-Calvo, I., Bubb, K. J., Pearl, V., Milsom, A. B., Khambata, R., Maleki-Toyserkani, S., Yousuf, M., Benjamin, N., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00933 · Cited by 218 · see citing works
George, A., Pushkaran, S., Konstantinidis, D. G., Koochaki, S., Malik, P., Mohandas, N., Zheng, Y., Joiner, C. H., & Kalfa, T. A. (2013) · Blood · doi:10.1182/blood-2012-07-441188 · Cited by 218 · see citing works
Aamand, R., Dalsgaard, T., Jensen, F. B., Simonsen, U., Roepstorff, A., & Fago, A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00525.2009 · Cited by 213 · see citing works
Tsai, A. G., Acero, C., Nance, P. R., Cabrales, P., Frangos, J. A., Buerk, D. G., & Intaglietta, M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00998.2004 · Cited by 211 · see citing works
Piezo1 regulates mechanotransductive release of ATP from human RBCs
Cinar, E., Zhou, S., DeCourcey, J., Wang, Y., Waugh, R. E., & Wan, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507309112 · Cited by 206 · see citing works
Schmidt, P. J., Toudjarska, I., Sendamarai, A. K., Racie, T., Milstein, S., Bettencourt, B. R., Hettinger, J., Bumcrot, D., & Fleming, M. D. (2013) · Blood · doi:10.1182/blood-2012-09-453977 · Cited by 204 · see citing works
Webb, A. J., Milsom, A. B., Rathod, K. S., Chu, W. L., Qureshi, S., Lovell, M. J., Lecomte, F. M. J., Perrett, D., Raimondo, C., Khoshbin, E., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.175810 · Cited by 203 · see citing works
Shear-dependent deformation of erythrocytes in rheology of human blood
Chien, S., Usami, S., Dellenback, R., & Gregersen, M. (1970) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1970.219.1.136 · Cited by 201 · cited 2× · see citing works
“While hematocrit values are the major determinant of blood viscosity, as a more packed fluid (increased hematocrit) blood is more resistant to flow (increased viscosity), a loss of de-formability in RBCs may increase viscosity significantly (34) due to increased end-over-end tumbling (61).”
Hemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease
Gladwin, M. T., Kanias, T., & Kim-Shapiro, D. B. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62972 · Cited by 196 · see citing works
Effect of Superoxide Anions on Red Blood Cell Rheologic Properties
Baskurt, O. K., Temiz, A., & Meiselman, H. J. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00169-x · Cited by 192 · see citing works
Oxidative denaturation of red blood cells in thalassemia.
Shinar, E., & Rachmilewitz, E. A. (1990) · PubMed · Cited by 190 · see citing works
The Redox Activity of Hemoglobins: From Physiologic Functions to Pathologic Mechanisms
Reeder, B. J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2974 · Cited by 189 · see citing works
Hemoglobin autoxidation and regulation of endogenous H2O2 levels in erythrocytes
Johnson, R. M., Goyette, G., Ravindranath, Y., & Ho, Y.-S. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.07.002 · Cited by 185 · see citing works
Endothelial nitric oxide synthase in red blood cells: Key to a new erythrocrine function?
Cortese-Krott, M. M., & Kelm, M. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.027 · Cited by 184 · see citing works
Self-citationGlutathione Reductase from Human Erythrocytes
WORTHINGTON, D. J., & ROSEMEYER, M. A. (1976) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1976.tb10654.x · Cited by 184 · see citing works
Cortese-Krott, M. M., Rodriguez-Mateos, A., Sansone, R., Kuhnle, G. G. C., Thasian-Sivarajah, S., Krenz, T., Horn, P., Krisp, C., Wolters, D., Heiß, C., et al. (2012) · Blood · doi:10.1182/blood-2012-07-442277 · Cited by 183 · see citing works
Self-citationArterial Hypertension Induced by Erythropoietin and Erythropoiesis-Stimulating Agents (ESA)
Krapf, R., & Hulter, H. N. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05040908 · Cited by 180 · see citing works
Inborn defects in the antioxidant systems of human red blood cells
van Zwieten, R., Verhoeven, A. J., & Roos, D. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.11.022 · Cited by 179 · see citing works
Multiscale approach to link red blood cell dynamics, shear viscosity, and ATP release
Forsyth, A. M., Wan, J., Owrutsky, P. D., Abkarian, M., & Stone, H. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101315108 · Cited by 175 · see citing works
The dynamic behavior of chemically “stiffened” red blood cells in microchannel flows
Forsyth, A. M., Wan, J., Ristenpart, W. D., & Stone, H. A. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.03.008 · Cited by 172 · see citing works
Red blood cells mediate the onset of thrombosis in the ferric chloride murine model
Barr, J., Chauhan, A. K., Schaeffer, G. V., et al. (2013) · Blood · doi:10.1182/blood-2012-11-468983 · Cited by 169 · see citing works
Inclusions of Hemoglobin in Erythroblasts and Erythrocytes of Thalassemia
Fessas, P. (1963) · Blood · doi:10.1182/blood.v21.1.21.21 · Cited by 169 · see citing works
Yashar, V. B., Barenholz, Y., Hy‐Am, E., Rachmilewitz, E. A., & Eldor, A. (1993) · American Journal of Hematology · doi:10.1002/ajh.2830440114 · Cited by 166 · see citing works
Southgate, C. D., Chishti, A. H., Mitchell, B., Yi, S. J., & Palek, J. (1996) · Nature Genetics · doi:10.1038/ng1096-227 · Cited by 160 · see citing works
SNO-hemoglobin is not essential for red blood cell–dependent hypoxic vasodilation
Isbell, T. S., Sun, C.-W., Wu, L.-C., Teng, X., Vitturi, D. A., Branch, B. G., Kevil, C. G., Peng, N., Wyss, J. M., Ambalavanan, N., et al. (2008) · Nature Medicine · doi:10.1038/nm1771 · Cited by 157 · see citing works
Vallés, J., Santos, M. T., Aznar, J., Martı́nez, M., Moscardó, A., Piñón, M., Broekman, M. J., & Marcus, A. J. (2002) · Blood · doi:10.1182/blood.v99.11.3978 · Cited by 152 · see citing works
Ferrucci, L., Guralnik, J. M., Bandinelli, S., Semba, R. D., Lauretani, F., Corsi, A., Ruggiero, C., Ershler, W. B., & Longo, D. L. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06502.x · Cited by 149 · see citing works
Gross, A. W., & Lodish, H. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510493200 · Cited by 149 · see citing works
Protective effect of arginine on oxidative stress in transgenic sickle mouse models
Dasgupta, T., Hebbel, R. P., & Kaul, D. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.08.025 · Cited by 148 · see citing works
Grubina, R., Huang, Z., Shiva, S., Joshi, M. S., Azarov, I., Basu, S., Ringwood, L. A., Jiang, A., Hogg, N., Kim‐Shapiro, D. B., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700546200 · Cited by 147 · see citing works
Hemoglobin-mediated nitric oxide signaling
Helms, C., & Kim-Shapiro, D. B. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.028 · Cited by 146 · see citing works
A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin
Kim, A., Fung, E., Parikh, S. G., Valore, E. V., Gabayan, V., Nemeth, E., & Ganz, T. (2014) · Blood · doi:10.1182/blood-2013-08-521419 · Cited by 145 · see citing works
Jain, S. K. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111958 · Cited by 138 · see citing works
Reactive Species in Sickle Cell Disease
ASLAN, M., THORNLEY‐BROWN, D., & FREEMAN, B. A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06201.x · Cited by 136 · see citing works
Anemia and splenomegaly in cGKI-deficient mice
Föller, M., Feil, S., Ghoreschi, K., Koka, S., Gerling, A., Thunemann, M., Hofmann, F., Schuler, B., Vogel, J., Pichler, B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708940105 · Cited by 136 · see citing works
THE MEMBRANE TRANSPORT OF ASCORBIC ACID<sup>*</sup>
Mann, G. V., & Newton, P. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb29285.x · Cited by 135 · see citing works
Pyruvate kinase deficiency in mice protects against malaria
Min-Oo, G., Fortin, A., Tam, M.-F., Nantel, A., Stevenson, M. M., & Gros, P. (2003) · Nature Genetics · doi:10.1038/ng1260 · Cited by 133 · see citing works
Rapid Regulation of Platelet Activation In Vivo by Nitric Oxide
Schäfer, A., Wiesmann, F., Neubauer, S., Eigenthaler, M., Bauersachs, J. K., & Channon, K. M. (2004) · Circulation · doi:10.1161/01.cir.0000126837.88743.dd · Cited by 133 · see citing works
Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease
Klings, E. S., & Farber, H. W. (2001) · Respiratory Research · doi:10.1186/rr70 · Cited by 132 · see citing works
Moustafa, M. E., Carlson, B. A., El-Saadani, M. A., Kryukov, G. V., Sun, Q.-A., Harney, J. W., Hill, K. E., Combs, G. F., Feigenbaum, L., Mansur, D. B., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.11.3840-3852.2001 · Cited by 131 · see citing works
Kay, M. M., Bosman, G. J., Shapiro, S. S., Bendich, A., & Bassel, P. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2463 · Cited by 130 · see citing works
Ott, I., Schulz, S., Mehilli, J., Fichtner, S., Hadamitzky, M., Hoppe, K., Ibrahim, T., Martinoff, S., Massberg, S., Laugwitz, K.-L., et al. (2010) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.109.904425 · Cited by 128 · see citing works
Wood, K. C., Cortese-Krott, M. M., Kovacic, J. C., Noguchi, A. C., Liu, V. B., Wang, X., Raghavachari, N., Boehm, M., Kato, G. J., Kelm, M., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301068 · Cited by 123 · see citing works
Self-citationGAMBARYAN, S., KOBSAR, A., HARTMANN, S., BIRSCHMANN, I., KUHLENCORDT, P. J., MÜLLER‐ESTERL, W., LOHMANN, S. M., & WALTER, U. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03014.x · Cited by 118 · see citing works
AUTOIMMUNE DISEASE IN NZB/BL MICE
Mellors, R. C. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.122.1.25 · Cited by 118 · see citing works
Anand, I. S., Chandrashekhar, Y., Wander, G. S., & Chawla, L. S. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00007-q · Cited by 116 · see citing works
Belcher, J. D., Chen, C., Nguyen, J., Zhang, P., Abdulla, F. A., Nguyen, P., Killeen, T. F., Xu, P. C., O'Sullivan, G., Nath, K. A., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6571 · Cited by 116 · see citing works
Nagababu, E., Fabry, M. E., Nagel, R. L., & Rifkind, J. M. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.12.003 · Cited by 114 · see citing works
Chiu, D., & Lubin, B. H. (1979) · PubMed · Cited by 114 · see citing works
New Treatment Approaches for the Anemia of CKD
Bonomini, M., Vecchio, L. D., Sirolli, V., & Locatelli, F. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.06.030 · Cited by 113 · see citing works
Ghoti, H., Amer, J., Winder, A., Rachmilewitz, E. A., & Fibach, E. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.00972.x · Cited by 110 · see citing works
Paradoxical hypotension following increased hematocrit and blood viscosity
Martini, J., Carpentier, B., Negrete, A. C., Frangos, J. A., & Intaglietta, M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00490.2005 · Cited by 109 · see citing works
Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice
Oldenborg, P. (2002) · Blood · doi:10.1182/blood.v99.10.3500 · Cited by 108 · see citing works
Bassand, J., Afzal, R., Eikelboom, J. W., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp401 · Cited by 108 · see citing works
Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase
Gambaryan, S., Geiger, J., Schwarz, U. R., Butt, E., Begonja, A., Obergfell, A., & Walter, U. (2004) · Blood · doi:10.1182/blood-2003-09-3349 · Cited by 107 · see citing works
Liu, S., Windisch, P., Kim, S., et al. (1984) · Cell · doi:10.1016/0092-8674(84)90389-1 · Cited by 104 · see citing works
Korcheva, V., Wong, J. W., Corless, C. L., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62256-0 · Cited by 101 · see citing works
Effects of blood viscosity on hemodynamic responses in acute normovolemic anemia
Murray, J. A., Escobar, E., & Rapaport, E. (1969) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1969.216.3.638 · Cited by 100 · see citing works
Pathobiology, classification, and diagnosis of myelodysplastic syndrome
Mufti, G. J. (2004) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.007 · Cited by 100 · see citing works
Brownlee, N. R., Huttner, J. J., Panganamala, R. V., & Cornwell, D. G. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41605-0 · Cited by 99 · see citing works
Bryszewska, M., Watala, C., & Torzecka, W. (1986) · British Journal of Haematology · doi:10.1111/j.1365-2141.1986.tb02906.x · Cited by 98 · see citing works
Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia.
Shinar, E., Rachmilewitz, E. A., & Lux, S. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113898 · Cited by 98 · see citing works
Stenvinkel, P. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_5.32 · Cited by 97 · see citing works
Su, D., May, J. M., Koury, M. J., & Asard, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606543200 · Cited by 93 · see citing works
Is anemia a new cardiovascular risk factor?
Kaiafa, G., Kanellos, I., Savopoulos, C., Kakaletsis, N., Giannakoulas, G., & Hatzitolios, A. I. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.159 · Cited by 92 · see citing works
Cao, Z., Bell, J. B., Mohanty, J. G., Nagababu, E., & Rifkind, J. M. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01233.2008 · Cited by 90 · see citing works
CONGENITAL METHEMOGLOBINEMIA. A CLINICAL AND BIOCHEMICAL STUDY OF A CASE 1
Eder, H. A., Finch, C., & McKee, R. W. (1949) · Journal of Clinical Investigation · doi:10.1172/jci102067 · Cited by 90 · see citing works
Glutathione reductase activity in red blood cells and riboflavin nutritional status in humans
Bamji, M. S. (1969) · Clinica Chimica Acta · doi:10.1016/0009-8981(69)90376-3 · Cited by 89 · see citing works
Red blood cell dynamics: from cell deformation to ATP release
Wan, J., Forsyth, A. M., & Stone, H. A. (2011) · Integrative Biology · doi:10.1039/c1ib00044f · Cited by 88 · cited 2× · see citing works
“These RBC intrinsic properties, together with the mechanisms regulating vascular tone and cardiac function, contribute to regulation of blood rheology, peripheral resistance, and cardiac function (114, 168, 188).”
Taniguchi, S., Dai, C.-H., Price, J. O., & Krantz, S. B. (1997) · Blood · doi:10.1182/blood.v90.6.2244 · Cited by 87 · see citing works
Tsuda, K., Kimura, K., Nishio, I., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3408 · Cited by 85 · see citing works
Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model
Jordan, M. B., van Rooijen, N., Izui, S., Kappler, J. W., & Marrack, P. (2002) · Blood · doi:10.1182/blood-2001-11-0061 · Cited by 83 · see citing works
Effect of Blood Nitrite and Nitrate Levels on Murine Platelet Function
Park, J. W., Piknova, B., Huang, P. L., Noguchi, C. T., & Schechter, A. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055699 · Cited by 82 · see citing works
Cabrales, P., Martini, J., Intaglietta, M., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01279.2005 · Cited by 82 · see citing works
Straub, A. C., Butcher, J. T., Billaud, M., Mutchler, S. M., Artamonov, M. V., Nguyen, A. T., Johnson, T., Best, A. K., Miller, M. P., Palmer, L. A., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303974 · Cited by 82 · see citing works
Self-citationRole of erythrocyte-released ATP in the regulation of microvascular oxygen supply in skeletal muscle
Ellsworth, M. L., Ellis, C. G., & Sprague, R. S. (2016) · Acta Physiologica · doi:10.1111/apha.12596 · Cited by 81 · see citing works
Friedman, J. S., Rebel, V. I., Derby, R. E., Bell, K., Huang, T., Kuypers, F. A., Epstein, C. J., & Burakoff, S. J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.925 · Cited by 80 · see citing works
Matte, A., Bertoldi, M., Mohandas, N., An, X., Bugatti, A., Brunati, A. M., Rusnati, M., Tibaldi, E., Siciliano, A., Turrini, F., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.543 · Cited by 80 · see citing works
Cappellini, M. D., Tavazzi, D., Duca, L., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01217.x · Cited by 80 · see citing works
Moyer, J., Nowak, R. B., Kim, N. E., Larkin, S. K., Peters, L. L., Hartwig, J. H., Kuypers, F. A., & Fowler, V. M. (2010) · Blood · doi:10.1182/blood-2010-02-268458 · Cited by 79 · see citing works
Westenbrink, B. D., Alings, M., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Oldgren, J., Yang, S., Pongue, J., Yusuf, S., Wallentin, L. C., et al. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12874 · Cited by 78 · see citing works
Jolanda Van der, Z. E. E., Steveninck, J. V., Koster, J. F., et al. (1989) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(89)90397-0 · Cited by 77 · see citing works
Mechanisms of Human Erythrocytic Bioactivation of Nitrite
Liu, C., Wajih, N., Liu, X., Basu, S., Janes, J., Marvel, M., Keggi, C., Helms, C. C., Lee, A. N., Belanger, A. M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.609222 · Cited by 76 · see citing works
Kawatani, Y., Suzuki, T., Shimizu, R., Kelly, V. P., & Yamamoto, M. P. (2010) · Blood · doi:10.1182/blood-2010-05-285817 · Cited by 74 · see citing works
Up-regulation of renal and vascular nitric oxide synthase in iron-deficiency anemia
Ni, Z., Morcos, S., & Vaziri, N. D. (1997) · Kidney International · doi:10.1038/ki.1997.319 · Cited by 72 · see citing works
Oxidative status of platelets in normal and thalassemic blood
Amer, J., & Fibach, E. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-04-0234 · Cited by 71 · see citing works
Pathobiology, classification, and diagnosis of myelodysplastic syndrome
Mufti, G. J. (2004) · Best Practice & Research Clinical Haematology · doi:10.1016/s1521-6926(04)00073-8 · Cited by 70 · see citing works
Effects of Aged Stored Autologous Red Blood Cells on Human Endothelial Function
Risbano, M. G., Kanias, T., Triulzi, D. J., Donadee, C., Barge, S., Badlam, J. B., Jain, S., Belanger, A., Kim‐Shapiro, D. B., & Gladwin, M. T. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0145oc · Cited by 69 · see citing works
Johnson, R., Ravindranath, Y., Elalfy, M. S., et al. (1994) · Blood · doi:10.1182/blood.v83.4.1117.1117 · Cited by 66 · see citing works
Effects of Malaria Heme Products on Red Blood Cell Deformability
Nuchsongsin, F., Chotivanich, K., Charunwatthana, P., Fausta, O.-S., Taramelli, D., Day, N., White, N. J., & Dondorp, A. M. (2007) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.617 · Cited by 62 · see citing works
Reinhart, W., Sung, L., & Chien, S. (1986) · Blood · doi:10.1182/blood.v68.6.1376.1376 · Cited by 60 · see citing works
Birkenmeier, C. S., McFarland-Starr, E. C., & Barker, J. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.8121 · Cited by 57 · see citing works
Jolicœur, E. M., O'Neill, W. W., Hellkamp, A., Hamm, C. W., Holmes, D. R., Al-Khalidi, H. R., Patel, M. R., Van de Werf, F. J., Pieper, K., Armstrong, P. W., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp279 · Cited by 54 · see citing works
Nitrosation, thiols, and hemoglobin: energetics and kinetics
Koppenol, W. H. (2012) · Inorganic Chemistry · doi:10.1021/ic202561f · Cited by 54 · see citing works
Jani, S. M., Smith, D. E., Share, D., Kline-Rogers, E., Khanal, S., O'Donnell, M. J., Gardin, J., & Moscucci, M. (2007) · Clinical Cardiology · doi:10.1002/clc.20236 · Cited by 54 · see citing works
Merx, M. W., Gorressen, S., Sandt, A. M., Cortese-Krott, M. M., Ohlig, J., Stern, M., Rassaf, T., Gödecke, A., Gladwin, M. T., & Kelm, M. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-013-0398-1 · Cited by 53 · see citing works
Self-citationThe role of oxidant injury in the pathophysiology of human thalassemias
Schrier, S. L., Centis, F., Verneris, M., Ma, L., & Angelucci, E. (2003) · Redox Report · doi:10.1179/135100003225002835 · Cited by 52 · see citing works
Nitric Oxide Synthetic Pathway in Red Blood Cells Is Impaired in Coronary Artery Disease
Eligini, S., Porro, B., Lualdi, A., Squellerio, I., Veglia, F., Chiorino, E., Crisci, M., Garlaschè, A., Giovannardi, M., Werba, J. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066945 · Cited by 52 · see citing works
Animal Models of Anemia of Inflammation
Rivera, S., & Ganz, T. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.06.003 · Cited by 48 · see citing works
Novel roles for erythroid Ankyrin-1 revealed through an ENU-induced null mouse mutant
Rank, G., Sutton, R., Marshall, V. M., et al. (2009) · Blood · doi:10.1182/blood-2008-08-172841 · Cited by 47 · see citing works
Relationship between oxidative stress, ferritin and insulin resistance in sickle cell disease.
Al‐Sultan, A. I., Seif, M. A., Amin, T. T., Mr, A. N., & AlSuliman, A. M. (2010) · PubMed · Cited by 46 · see citing works
Iuchi, Y., Okada, F., Takamiya, R., Kibe, N., Tsunoda, S., Nakajima, O., Toyoda, K., Nagae, R., Suematsu, M., Soga, T., et al. (2009) · Biochemical Journal · doi:10.1042/bj20090176 · Cited by 45 · see citing works
The anemia of “haemoglobin-deficit” (hbd/hbd) mice is caused by a defect in transferrin cycling
Zhang, A., Sheftel, A. D., & Ponka, P. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.02.004 · Cited by 44 · see citing works
Krieger, C. C., An, X., Tang, H., Mohandas, N., Speicher, D. W., & Discher, D. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018887108 · Cited by 39 · see citing works
Mouse models of IgG- and IgM-mediated hemolysis
Schirmer, D. A., Song, S., Baliff, J. P., Harbers, S. O., Clynes, R., Krop‐Watorek, A., Halverson, G. R., Czerwiński, M., & Spitalnik, S. L. (2006) · Blood · doi:10.1182/blood-2006-08-040139 · Cited by 39 · see citing works
Baudino, L., Fossati‐Jimack, L., Chevalley, C., Martínez-Soria, E., Shulman, M. J., & Izui, S. (2007) · Blood · doi:10.1182/blood-2006-11-059899 · Cited by 38 · see citing works
Hemodynamic Effects of Anemia with and without Plasma Volume Expansion
Fowler, N. O., Franch, R. H., Bloom, W. L., & Ward, J. A. (1956) · Circulation Research · doi:10.1161/01.res.4.3.319 · Cited by 37 · see citing works
Rousseau, M., Yan, R. T., Tan, M., Lefkowitz, C. J., Casanova, A., Fitchett, D., Jolly, S. S., Langer, A., Goodman, S. G., & Yan, A. T. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.07.009 · Cited by 37 · see citing works
Effects of nitric oxide and its congeners on sickle red blood cell deformability
Belanger, A. M., Keggi, C., Kanias, T., Gladwin, M. T., & Kim‐Shapiro, D. B. (2015) · Transfusion · doi:10.1111/trf.13134 · Cited by 37 · see citing works
Jain, S. K., & Williams, D. M. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90339-0 · Cited by 37 · see citing works
SOD2-Deficiency Sideroblastic Anemia and Red Blood Cell Oxidative Stress
Martin, F. M., Bydłoń, G., & Friedman, J. S. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1217 · Cited by 36 · see citing works
Mohanty, J. G., Nagababu, E., Friedman, J. S., & Rifkind, J. M. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.10.017 · Cited by 35 · see citing works
Red Blood Cell Membrane-Facilitated Release of Nitrite-Derived Nitric Oxide Bioactivity
Salgado, M. T., Cao, Z., Nagababu, E., Mohanty, J. G., & Rifkind, J. M. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00643 · Cited by 34 · see citing works
Nitric oxide influences red blood cell velocity independently of changes in the vascular tone
Horn, P., Cortese-Krott, M. M., Keymel, S., Kumara, I., Burghoff, S., Schrader, J., Kelm, M., & Kleinbongard, P. (2011) · Free Radical Research · doi:10.3109/10715762.2011.574288 · Cited by 34 · cited 2× · see citing works
“Additionally, according to basic science studies, RBCs may control systemic hemodynamics by influencing blood rheological properties and contribute to tissue protection and cardiovascular homeostasis (40, 73, 82).”
Self-citationMouse models of sickle cell disease
Beuzard, Y. (2008) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2008.04.001 · Cited by 34 · see citing works
Akrawinthawong, K., Park, J. W., Piknova, B., Sibmooh, N., Fucharoen, S., & Schechter, A. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092435 · Cited by 32 · see citing works
Ducrocq, G., Puymirat, E., Steg, P. G., Henry, P., Martelet, M., Karam, C., Schiele, F., Simon, T., & Danchin, N. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.07.004 · Cited by 32 · see citing works
Lu, Y., Hanada, T., Fujiwara, Y., Nwankwo, J. O., Wieschhaus, A. J., Hartwig, J. H., Huang, S., Han, J., & Chishti, A. H. (2016) · Blood · doi:10.1182/blood-2016-01-692251 · Cited by 30 · see citing works
Circulating NOS3 Modulates Left Ventricular Remodeling following Reperfused Myocardial Infarction
Gorressen, S., Stern, M., van de Sandt, A. M., Cortese-Krott, M. M., Ohlig, J., Rassaf, T., Gödecke, A., Fischer, J. W., Heusch, G., Merx, M. W., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120961 · Cited by 29 · see citing works
Self-citationEffect of Ascorbate on Red Blood Cell Lipid Peroxidation
Einsele, H., Clemens, M., & Remmer, H. (1985) · Free Radical Research Communications · doi:10.3109/10715768509056537 · Cited by 28 · see citing works
Peters, L. L., LANE, P. W., Andersen, S. G., et al. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0454 · Cited by 27 · see citing works
Thrombotic Risks in Red Blood Cell Transfusions
Dubovoy, T. Z., & Engoren, M. (2016) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0035-1569069 · Cited by 27 · see citing works
Iron Status, Anemia, and Plasma Erythropoietin Levels in Acute and Chronic Mouse Models of Colitis
Carter, P. R., Watts, M. N., Kosloski-Davidson, M., Prasai, K., Grisham, M. B., & Harris, N. R. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182813466 · Cited by 25 · see citing works
Giustino, G., Kirtane, A. J., Généreux, P., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.03.001 · Cited by 23 · see citing works
Acute and chronic cardiovascular adjustments to induced anemia in dogs
Neill, W. A., Oxendine, J., & Moore, S. B. (1969) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1969.217.3.710 · Cited by 23 · see citing works
Systemic blood pressure profile in hypertensive patients with low hemoglobin concentrations
Marketou, M. E., Patrianakos, A. P., PARTHENAKIS, F. I., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.11.096 · Cited by 22 · see citing works
Grzelak, A., Kruszewski, M. K., Macierzyńska, E., Piotrowski, Ł., Pułaski, Ł., Rychlik, B., & Bartosz, G. (2008) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-008-0031-8 · Cited by 20 · see citing works
Halis, H., Bor-Küçükatay, M., Akın, M., et al. (2009) · Pediatric Hematology and Oncology · doi:10.1080/08880010902754909 · Cited by 20 · see citing works
Impaired expression of HIF-2α induces compensatory expression of HIF-1α for the recovery from anemia
Tsuboi, I., Yamashita, T., Nagano, M., Kimura, K., Salazar, G. T., & Ohneda, O. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24899 · Cited by 18 · see citing works
Murine Models of Paroxysmal Nocturnal Hemoglobinuria
Rosti, V. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04120.x · Cited by 18 · see citing works
Deonikar, P., & Kavdia, M. (2012) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2012.10.025 · Cited by 16 · see citing works
Demetz, G., Laux, M., Scherhag, A., Hoekstra, T., Suttorp, M. M., Dekker, F., Roest, M., Marcus-Kalish, M., Mittelman, M., & Ott, I. (2014) · Thrombosis Journal · doi:10.1186/1477-9560-12-18 · Cited by 16 · see citing works
Effects of Viscosity on Cerebral Blood Flow After Cardiac Arrest
Bisschops, L. L. A., Pop, G., Teerenstra, S., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0000000000000027 · Cited by 15 · see citing works
Circulatory haemodynamics after blood transfusion in chronic severe anaemia.
Sanghvi, L. M., Kc, K., Sharma, S., et al. (1968) · Heart · doi:10.1136/hrt.30.1.125 · Cited by 15 · see citing works
Liberation of ATP secondary to hemolysis is not mutually exclusive of regulated export
Kirby, B. S., Schwarzbaum, P. J., Lazarowski, E. R., et al. (2015) · Blood · doi:10.1182/blood-2014-11-609610 · Cited by 15 · see citing works
Sikora, J., Orlov, S. N., Furuya, K., et al. (2015) · Blood · doi:10.1182/blood-2015-01-622159 · Cited by 11 · see citing works
Tomita, H., Fuchimoto, Y., Mori, T., et al. (2013) · Clinical Transplantation · doi:10.1111/ctr.12264 · Cited by 8 · see citing works
Experimental model of autoimmune hemolytic anemia induced in mice with Levodopa
Sharon, R., & Naor, D. (1989) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(89)90169-4 · Cited by 8 · see citing works
A novel acute anemia model for pharmacological research in mice by compelled acute exercise
Liu, Q., Wang, J., Cui, J., et al. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.161 · Cited by 7 · see citing works
Recombinant Human Erythropoietin and Its Effects on Macro- and Microcirculation during Normovolemia
Wirtz, J. J. J. M., Leunissen, K. M. L., van Esser, J. W. J., et al. (2008) · Blood Purification · doi:10.1159/000169980 · Cited by 7 · see citing works
Yeşilkaya, A., & Yeĝin, A. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)00285-1 · Cited by 5 · see citing works
Walker, J. A., Hall, A. M., Kotsopoulou, E., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201242633 · Cited by 3 · see citing works
Flagged first, then by citations
Research works printed but not linked: 8
- Alsultan AI, 2010, Eur Rev Med Pharmacol Sci, 14, 527
- Chiu D, 1979, J Lab Clin Med, 94, 542
- GuytonAC and HallJE. Textbook of Medical Physiology. Philadelphia: Elsevier Saunders, 2006, xxxv, p. 1116.
- Pfafferott C, 1985, Effects of internal and external phase viscosity and of in vivo aging. Biophys J, 47, 695
- Shinar E, 1990, Semin Hematol, 27, 70
- Simchon S, 1987, Am J Physiol, 253, H898
- WHO, 2011, Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. Vitamin and Mineral Nutrition Information System
- Wintrobe MM., 1934, Arch Int Med, 20, 987
Cited by
Sorted by citations
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541 · see citing works
The Emerging Role of Vitamin C as a Treatment for Sepsis
Kashiouris, M. G., L’Heureux, M., Cable, C. A., Fisher, B. J., Leichtle, S. W., & Fowler, A. A. (2020) · Nutrients · doi:10.3390/nu12020292 · Cited by 177 · see citing works
Oxidative stress’s impact on red blood cells: Unveiling implications for health and disease
Obeagu, E. I., Igwe, M. C., & Obeagu, G. U. (2024) · Medicine · doi:10.1097/md.0000000000037360 · Cited by 95 · see citing works
- Authors
- Kuhn, V., Diederich, L., Keller, T. C. S., Kramer, C. M., Lückstädt, W., Panknin, C., Suvorava, T., Isakson, B. E., Kelm, M., & Cortese-Krott, M. M.
- Affiliations
- Heinrich Heine University Düsseldorf (DE)
- University of Virginia (US)
- Corresponding author
- Cortese-Krott, Miriam M.
- ORCID
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2017-05
- Volume
- 26
- Issue
- 13
- Pages
- 718-742
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- PMC
- PMC5421513
- OpenAlex
- W2558688385
- Semantic Scholar
- 9e37cabe13f5c23e031f935234be9fa2bc6ec2b1
- Cited by
- 469
- References
- 198
- Citations by year
- 2026: 38 · 2025: 54 · 2024: 69 · 2023: 62 · 2022: 70 · 2021: 62 · 2020: 52 · 2019: 36 · 2018: 23 · 2017: 2 · 2014: 1
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Antioxidants and Redox Signaling (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- American Heart Association (16PRE31180040)
- Deutsche Forschungsgemeinschaft (DFG CO 1305/2-1, CO 1305/2-1)
- Servier
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL088554)
- Topics
- Health Sciences › Medicine › Physiology › Erythrocyte Function and Pathophysiology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Blood properties and coagulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hemoglobin structure and function
- Keywords
- red blood cell function, redox regulation, nitric oxide metabolism, anemia, inter-organ communication, hemorheology, blood viscosity, oxidative stress, elderly patients
- MeSH terms
- Anemia, Animals, Erythrocytes, Humans, Nitric Oxide, Oxidation-Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review